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Abstract
Choices for genome engineering and integration involve high efficiency with little or no target specificity or
high specificity with low activity. Here, we describe a targeted integration strategy, called GeneWeld, and a
vector series for gene tagging, pGTag (plasmids for Gene Tagging), which promote highly efficient and
precise targeted integration in zebrafish embryos, pig fibroblasts, and human cells utilizing the CRISPR/Cas9
system. Our work demonstrates that in vivo targeting of a genomic locus of interest with CRISPR/Cas9 and a
donor vector containing as little as 24 to 48 base pairs of homology directs precise and efficient knock-in when
the homology arms are exposed with a double strand break in vivo. Given our results targeting multiple loci in
different species, we expect the accompanying protocols, vectors, and web interface for homology arm design
to help streamline gene targeting and applications in CRISPR compatible systems.
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In  Brief    
  
   Wierson  et  al.  describe  a  targeted  integration  strategy,  called  GeneWeld,  and  a  vector  
series  for  gene  tagging,  pGTag,  which  promote  highly  efficient  and  precise  targeted  integration  
in  zebrafish,  pig  fibroblasts,  and  human  cells.  This  approach  establishes  an  effective  genome  
engineering  solution  that  is  suitable  for  creating  knock-­in  mutations  for  functional  genomics  and  
gene  therapy  applications.  The  authors  describe  high  rates  of  germline  transmission  (50%)  for  
targeted  knock-­ins  at  eight  different  zebrafish  loci  and  efficient  integration  at  safe  harbor  loci  in  




   Choices  for  genome  engineering  and  integration  involve  high  efficiency  with  little  or  no  
target  specificity  or  high  specificity  with  low  activity.  Here,  we  describe  a  targeted  integration  
strategy,  called  GeneWeld,  and  a  vector  series  for  gene  tagging,  pGTag  (plasmids  for  Gene  
Tagging),  which  promote  highly  efficient  and  precise  targeted  integration  in  zebrafish  embryos,  
pig  fibroblasts,  and  human  cells  utilizing  the  CRISPR/Cas9  system.  Our  work  demonstrates  that  
in  vivo  targeting  of  a  genomic  locus  of  interest  with  CRISPR/Cas9  and  a  donor  vector  containing  
as  little  as  24  to  48  base  pairs  of  homology  directs  precise  and  efficient  knock-­in  when  the  
homology  arms  are  exposed  with  a  double  strand  break  in  vivo.  Given  our  results  targeting  
multiple  loci  in  different  species,  we  expect  the  accompanying  protocols,  vectors,  and  web  
interface  for  homology  arm  design  to  help  streamline  gene  targeting  and  applications  in  
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   Designer  nucleases  have  rapidly  expanded  the  way  in  which  researchers  can  utilize  
endogenous  DNA  repair  mechanisms  for  creating  gene  knock-­outs,  reporter  gene  knock-­ins,  
gene  deletions,  single  nucleotide  polymorphisms,  and  epitope  tagged  alleles  in  diverse  species  
(Bedell  et  al.,  2012;;  Beumer  et  al.,  2008;;  Carlson  et  al.,  2012;;  Geurts  et  al.,  2009;;  Yang  et  al.,  
2013).  A  single  dsDNA  break  in  the  genome  results  in  increased  frequencies  of  recombination  
and  promotes  integration  of  homologous  recombination  (HR)-­based  vectors  (Hasty  et  al.,  1991;;  
Hoshijima  et  al.,  2016;;  Orr-­Weaver  et  al.,  1981;;  Rong  and  Golic,  2000;;  Shin  et  al.,  2014;;  Zu  et  
al.,  2013).  Additionally,  in  vitro  or  in  vivo  linearization  of  targeting  vectors  stimulates  homology-­
directed  repair  (HDR)  (Hasty  et  al.,  1991;;  Hoshijima  et  al.,  2016;;  Orr-­Weaver  et  al.,  1981;;  Rong  
and  Golic,  2000;;  Shin  et  al.,  2014;;  Zu  et  al.,  2013).  Utilizing  HDR  or  HR  at  a  targeted  double-­
strand  break  (DSB)  allows  base-­pair  precision  to  directionally  knock-­in  exogenous  DNA,  
however,  frequencies  remain  variable  and  engineering  of  targeting  vectors  is  cumbersome.      
  
   Previous  work  has  shown  Xenopus  oocytes  have  the  ability  to  join  or  recombine  linear  
DNA  molecules  that  contain  short  regions  of  homology  at  their  ends,  and  this  activity  is  likely  
mediated  by  exonuclease  activity  allowing  base  pairing  of  the  resected  homology  (Grzesiuk  and  
Carroll,  1987).  More  recently,  it  was  shown  in  Xenopus,  silkworm,  zebrafish,  and  mouse  cells  
that  a  plasmid  donor  containing  short  (≤40  bp)  regions  of  homology  to  a  genomic  target  site  can  
promote  precise  integration  at  the  genomic  cut  site  when  the  donor  plasmid  is  cut  adjacent  to  
the  homology  (Aida  et  al.,  2016;;  Hisano  et  al.,  2015;;  Nakade  et  al.,  2014).  Gene  targeting  is  
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likely  mediated  by  the  alternative-­end  joining/microhomology-­mediated  end  joining  (MMEJ)  
pathway  or  by  a  single  strand  annealing  (SSA)  mechanism  (Ceccaldi  et  al.,  2016).  In  contrast,  in  
human  cell  culture,  linear  donors  with  homologous  ends  have  been  reported  to  show  inefficient  
integration  until  homology  domains  reach  ~600  bp  (Zhang  et  al.,  2017),  suggesting  that  different  
repair  pathways  may  predominate  depending  on  cell  type.  In  the  initial  reports  using  short  
regions  of  homology  for  in  vivo  gene  targeting  in  zebrafish,  the  level  of  mosaicism  in  F0  injected  
animals  was  high,  resulting  in  inefficient  recovery  of  targeted  alleles  through  the  germline  (Aida  
et  al.,  2016;;  Hisano  et  al.,  2015;;  Nakade  et  al.,  2014).  
  
Here,  we  present  GeneWeld,  a  strategy  for  targeted  integration  directed  by  short  
homology,  and  demonstrate  increased  germline  transmission  rates  for  recovery  of  targeted  
alleles.  We  provide  a  detailed  protocol  and  a  suite  of  donor  vectors,  called  pGTag,  that  can  be  
easily  engineered  with  homologous  sequences  (hereafter  called  homology  arms)  to  a  gene  of  
interest,  and  a  web  interface  for  designing  homology  arms  (www.genesculpt.org/gtaghd/).  We  
demonstrate  that  24  or  48  base  pairs  of  homology  directly  flanking  cargo  DNA  promotes  
efficient  gene  targeting  in  zebrafish,  pig,  and  human  cells  with  frequencies  up  to  10-­fold  higher  
than  other  HR  strategies.  Using  short  homology-­arm  mediated  end  joining,  we  can  achieve  
germline  transmission  rates  averaging  approximately  50%  across  several  zebrafish  loci.  
Southern  blot  analysis  in  the  F1  generation  reveals  that  the  GeneWeld  strategy  can  yield  alleles  
with  precise  integration  at  both  5’  and  3’  ends,  as  well  as  alleles  that  are  precise  on  just  one  
end.  Finally,  we  present  a  strategy  to  delete  and  replace  up  to  48kb  of  genomic  DNA  with  a  
donor  containing  homology  arms  flanking  two  distal  CRISPR/Cas9  sites  in  a  gene.  These  tools  
and  methodology  provide  a  tractable  solution  to  creating  precise  targeted  integrations  and  open  
the  door  for  other  genome  editing  strategies  using  short  homology.  
  
Design  
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The  GeneWeld  strategy  takes  advantage  of  two  simultaneous  actions  to  initiate  targeted  
integration  directed  by  short  homology  (Fig.  1a).  First,  a  high  efficiency  nuclease  introduces  a  
DSB  in  the  chromosomal  target.  Simultaneously,  a  second  nuclease  makes  a  DSB  in  the  
pGTag  vector  integration  cassette  exposing  the  short  homology  arms.  The  complementarity  
between  the  chromosomal  DSB  and  the  donor  homology  arms  activates  a  MMEJ/SSA  or  other  
non-­NHEJ  DNA  repair  mechanism,  referred  to  as  homology-­mediated  end  joining  (HMEJ).  The  
reagents  needed  for  this  gene  targeting  strategy  include  Cas9  mRNA  to  express  the  Cas9  
nuclease,  a  guide  RNA  targeting  the  genomic  sequence  of  interest,  a  universal  gRNA  (UgRNA)  
that  targets  two  sites  in  the  pGTag  series  donor  vectors  to  expose  the  homology  arms,  and  a  
pGTag/donor  vector  with  gene  specific  homology  arms  (Fig.  1a).  The  universal  gRNA  (UgRNA)  
has  no  predicted  sites  in  zebrafish,  pig,  or  human  genomes.  Alternatively,  a  gene  specific  guide  
RNA  can  be  used  to  expose  homology  arms  in  the  donor  vector.  For  simplicity  we  will  refer  to  
this  set  of  reagents  as  ‘GeneWeld  reagents’.  Using  GeneWeld  reagents  to  target  various  loci,  
we  demonstrate  widespread  reporter  gene  expression  in  injected  F0  zebrafish  embryos,  porcine  
fibroblasts,  and  human  K-­562  cells,  indicating  efficient  and  precise  in-­frame  integration  in  




A  single  homology  domain  of  up  to  48  bp  drives  efficient  integration  of  RFP  into  noto  
To  develop  baseline  gene  targeting  data,  we  engineered  variable  length  homology  
domains  to  target  noto.  These  lengths  were  based  on  observations  that  DNA  repair  enzymes  
bind  DNA  and  search  for  homology  in  3  or  4  base  pair  lengths  (Supplementary  Fig.  1a)    
(Conway  et  al.,  2004;;  Singleton  et  al.,  2002).  Upon  injection  of  a  noto  sgRNA  to  target  both  the  
genome  and  one  homology  domain  of  a  2A-­TagRFP-­CAAX-­SV40  donor  vector,  efficient  
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integration  was  observed  as  notochord-­specific  RFP  (Supplementary  Fig.  1b,  c,  Supplementary  
Table  1-­3).  The  frequency  of  RFP  expression  increased  as  the  homology  domain  was  expanded  
up  to  48  bp  (Supplementary  Fig.  1b),  while  192  bp  of  homology  displayed  reduced  integration  
activity  (data  not  shown).  Somatic  junction  fragment  analysis  showed  precise  integration  
efficiencies  reaching  95%  of  sequenced  alleles  (Supplementary  Fig.  1d).  Following  these  initial  
experiments,  a  3  bp  spacer  sequence  was  included  in  all  homology  arm  designs  to  separate  the  
donor  CRISPR/Cas9  target  PAM  and  the  homology  domain  and  prevent  arbitrarily  increasing  
the  length  of  the  targeting  domain,  as  single  base  pair  alterations  in  the  homology  region  can  
affect  knock-­in  efficiency  up  to  2-­fold  (Supplementary  Fig.  2).    
  
Using  the  UgRNA  to  Liberate  Donor  Homology  
To  simplify  donor  design  and  liberate  donor  cargo  in  vivo  with  reproducible  efficiency,  a  
UgRNA  sequence,  with  no  predicted  targets  in  zebrafish,  pig,  or  human  cells,  was  designed  
based  on  optimal  base  composition  (Supplementary  Fig.  3a)  (Moreno-­Mateos  et  al.,  2015).  The  
target  sequence  for  the  UgRNA  with  a  PAM  sequence  was  cloned  5’  adjacent  to  the  homology  
arm  in  a  donor  vector  to  direct  a  DSB  for  homology  exposure.  Experiments  targeting  noto  with  
this  UgRNA  donor  plasmid  resulted  in  RFP  expression  in  the  notochord  in  21%  of  injected  
embryos,  indicating  correct  targeting  of  noto  and  demonstrating  the  efficacy  of  Cas9/UgRNA  to  
expose  the  single  5’  homology  arm  in  the  donor  and  drive  precise  integration  (Supplementary  
Fig.  2b,  3c).  The  high  frequency  of  RFP+  cells  following  injection  of  GeneWeld  reagents  
suggests  that  repair  of  the  DSB  preferentially  utilizes  the  homology  in  the  targeting  construct  
over  the  NHEJ  pathway.  
  
Liberating  Short  Homology  by  Dual  Targeting  of  Donor  Vectors  and  Genomic  Loci  
Directs  Precise  Integration  in  Somatic  Tissue  
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   We  leveraged  the  activity  of  the  UgRNA  in  the  design  of  the  pGTag  vector  series  by  
including  UgRNA  target  sites  on  both  ends  of  the  cargo  (Fig.  1b).  Homology  arms  can  be  simply  
added  to  the  vectors  using  Golden  Gate  cloning.  Cleavage  by  Cas9  at  the  UgRNA  sites  in  the  
embryo  or  cell  liberates  the  DNA  cargo  from  the  plasmid  backbone  and  exposes  both  5’  and  3’  
homology  arms  for  interaction  with  DNA  on  either  side  of  the  genomic  DSB  (Fig.  1c).  Injection  of  
GeneWeld  reagents  containing  either  2A-­TagRFP-­CAAX-­SV40  or  2A-­eGFP-­SV40  donors  
targeting  noto  resulted  in  24%  of  embryos  showing  extensive  notochord  expression  of  the  
reporter,  indicating  a  similar  targeting  efficiency  compared  to  targeting  with  5’  homology  alone  
(Fig.  2a,  e;;  Supplementary  Fig.  1,  Table  1-­3).    
  
To  extend  our  results  to  other  loci  in  zebrafish,  we  targeted  different  genes  with  2A-­
TagRFP-­CAAX-­SV40  and  varying  homologies  (Fig.  2,  Supplementary  Table  1-­4).  GeneWeld  
reagents  targeting  connexin43.4  (cx43.4)  with  24  and  48  bp  of  homology  resulted  in  broad  RFP  
expression  throughout  the  nervous  system  and  vasculature  in  38  to  50%  of  the  injected  
embryos  (Fig.  2b,  e).  Together,  these  results  suggest  that  24  bp  of  homology  directs  targeted  
integration  as  efficiently  as  48  bp.      
  
Targeting  exon  4  of  tyrosinase  (tyr)  with  GeneWeld  reagents  did  not  result  in  detectable  
RFP  signal,  similar  to  previous  reports  (Hisano  et  al.,  2015).  However,  PCR  junction  fragments  
from  injected  larvae  showed  the  2A-­TagRFP-­CAAX-­SV40  donor  was  precisely  integrated  in  
frame  into  tyr  exon  4  (Supplementary  Fig.  5),  suggesting  RFP  expression  was  below  the  
threshold  of  detection.  To  amplify  the  fluorescent  signal,  we  injected  homology  directed  pGTag-­
2A-­Gal4VP16-­b-actin  to  integrate  the  transactivator  Gal4VP16  into  the  tyr  exon  4  target  site  in  
transgenic  zebrafish  embryos  carrying  a  14xUAS-­RFP  reporter,  Tg(UAS:mRFP)tpl2  (Balciuniene  
et  al.,  2013).  This  resulted  in  strong  RFP  signal  in  64%  of  injected  animals;;  however,  the  
embryos  were  highly  mosaic  compared  to  targeting  2A-­TagRFP-­CAAX-­SV40  into  noto  and  
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cx43.4,  with  only  9%  of  RFP  embryos  displaying  extensive  expression  throughout  pigmented  
cells  (Fig.  2c,  e).    
  
Similar  to  tyr,  GeneWeld  reagents  used  for  targeting  2A-­TagRFP-­CAAX-­SV40  into  exon  
2  of  the  esama  gene  did  not  result  in  detectable  RFP  expression,  however,  targeting  pGTag-­2A-­
Gal4VP16  in  the  Tg(UAS:mRFP)tpl2  transgenic  background  resulted  in  21%  of  embryos  
displaying  extensive  RFP  expression  specifically  in  the  vasculature  (Fig.  2d,  e).  This  approach  
was  further  extended  to  five  additional  loci,  targeting  2A-­Gal4VP16  to  filamin  a  (flna),  moesin  a  
(msna),  aquaporin  1a1  (aqp1a1),  aquaporin  8a1  (aqp8a1),  and  annexin  a2a  (anxa2a).  At  these  
loci,  transient  expression  of  RFP  was  observed  following  injection  in  4-­55%  of  
Tg(UAS:mRFP)tpl2  embryos  (Supplementary  Table  1  and  2).  Taken  together,  these  results  show  
that  the  application  of  GeneWeld  reagents  promotes  high  efficiency  somatic  integration  
following  injection  into  zebrafish  embryos.    
  
Efficient  germline  transmission  
Three  out  of  five  (60%)  noto-­2A-­TagRFP-­CAAX-­SV40  injected  founder  fish  raised  to  
adulthood  transmitted  noto-­2A-­TagRFP-­CAAX-­SV40  tagged  alleles  through  the  germline  
(Figure  3,  Table  1,  Supplementary  Tables  3  and  4).  For  tyr-­2A-­Gal4VP16-­b-actin  injections,  8  
embryos  with  expression  in  the  retinal  pigmented  epithelia  were  raised  to  adulthood  and  
outcrossed.  Of  those,  three  founder  animals  transmitted  tagged  alleles  to  the  next  generation  
(37.5%)  (Figure  3,  Table  1  and  Supplementary  Table  3  and  4).  Likewise,  for  esama-­2A-­
Gal4VP16-­β-­actin,  18  F0s  displaying  widespread  vasculature  RFP  expression  were  raised  to  
adulthood,  and  12  (66.7%)  transmitted  esama-­2A-­Gal4VP16-­β-­actin  alleles  to  the  F1  
generation.  We  have  extended  these  results  to  flna,  two  different  target  sites  in  msna  (exon  2  
and  6),  aqp1a1,  aqp8a1,  and  anxa2a  with  a  combined  F0  transmission  rate  of  49%  across  all  
loci  (Figure  3,  Table  1,  Supplementary  Tables  3  and  4).  Taken  together,  these  results  indicate  
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GeneWeld  reagents  which  efficiently  promote  targeted  integration  in  zebrafish  F0s  based  on  
reporter  expression  are  also  efficiently  transmitted  through  the  germline.    
  
Precise  5’  and  3’  junctions  and  single  copy  integration  in  F1s  
   Given  that  homology  was  present  on  both  sides  of  the  pGTag  constructs  used  for  
targeting,  it  was  expected  that  precise  integration  would  occur  at  both  5’  and  3’  of  the  genomic  
cut  site.  Genomic  Southern  blot  analyses  of  four  F1s  from  two  of  the  noto-­2A-­TagRFP-­CAAX-­
SV40  founders  confirmed  a  single  copy  integration  in  noto  exon  1  (Fig.  4,  a-­c).  Progeny  from  the  
first  founder  had  precise  integrations  at  the  5’  end  of  the  target  site  but  contained  an  ~400  bp  
deletion  downstream  extending  into  exon  2.  The  second  founder  produced  offspring  with  an  
allele  with  precise  5’  integration  and  also  included  an  insertion  at  the  3’  end,  likely  to  be  a  
segment  of  the  vector  backbone  based  on  the  size  of  the  insert  on  Southern  blot.  Sequencing  of  
junction  fragments  from  the  first  founder  confirmed  that  NHEJ  drove  integration  at  the  3’  end  
rather  than  a  homology-­based  mechanism  which  was  not  expected  (Fig.  4,  Supplementary  Fig.  
4).  In  contrast,  Southern  blot  analysis  and  sequencing  of  tyr-­2A-­Gal4VP16-­b-­actin  F1  progeny  
demonstrated  a  single  copy  integration  of  the  Gal4VP16  cassette  with  precise  integration  at  
both  5’  and  3’  ends  (Fig.  4,  d-­f,  Supplementary  Fig.  4,  5).    
  
   Junction  fragment  analysis  of  F1s  from  each  of  seven  transmitting  loci  indicated  precise  
events  were  primarily  recovered  at  the  5’  for  all  the  genes  examined  (30/31  or  97%  across  
seven  genes)  (Supplementary  Fig.  4).  This  result  is  expected  as  precise  5’  integrations  are  
selected  for  by  screening  for  expression  of  the  report  from  the  donor  cassette.    For  esama,  the  
3’  junctions  were  also  precise  in  9/10  of  the  F1s  examined  from  6  different  F0s,  and  both  
aqp1a1  and  app8a1  had  precise  3’  junctions.  This  is  compared  to  msna  E2  targeting  with  2A-­
Gal4VP16-­b-­actin,  where  only  one  out  of  the  12  F1s  examined  had  a  precise  3’  junction.  
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Together,  these  results  indicate  that  GeneWeld  reagents  can  promote  precise  single  copy  
integration  at  a  genomic  cut  site  without  vector  sequences,  although  events  involving  NHEJ  at  
the  at  the  3’  end  are  also  recovered.  
  
Homology  Engineered  to  Distal  Genomic  gRNA  Sites  Seeds  Deletion  Tagging  in  Somatic  
Tissue    
To  further  demonstrate  the  utility  of  GeneWeld  reagents,  we  tested  whether  the  pGTag  
donors  could  function  to  bridge  two  CRISPR/Cas9  genomic  cuts,  resulting  in  simultaneous  
deletion  of  endogenous  sequences  and  integration  of  exogenous  DNA  to  create  a  “deletion  
tagged”  allele.  The  pGTag-­2A-­Gal4VP16  donor  was  cloned  with  homology  arms  to  two  gRNA  
target  sites  in  the  zebrafish  retinoblastoma1  (rb1)  gene.  The  two  gRNA  sites  were  located  in  
exons  2  and  4,  which  are  located  394  bp  apart,  or  in  exons  2  and  25  which  are  separated  by  
~48.4  kb  (Fig.  5a).  The  5’  homology  arm  contained  sequence  upstream  of  the  cut  site  in  exon  2,  
while  the  3’  homology  arm  contained  sequence  downstream  of  the  cut  site  in  either  exon  4  or  
exon  25.  Injection  of  GeneWeld  reagents  with  the  corresponding  exon  2-­exon  4  or  exon  2-­exon  
25  pGTag-­2A-­Gal4VP16-­β-­actin  donor  into  Tg(UAS:mRFP)tpl2  embryos  resulted  in  59%  and  
60%,  respectively,  of  injected  embryos  showing  broad  and  ubiquitous  RFP  expression  (Fig.  5b-­
c,  f,  Supplementary  Table  1,2).  Somatic  junction  fragment  analysis  showed  precise  integration  
at  both  the  5’  (29/30  or  97%  of  the  fragments  analyzed)  and  3’  ends  (20/30  or  67%)  of  rb1  
(Supplementary  Fig.  6).  Increasing  the  size  of  the  deleted  region  from  394  bp  to  48.4  Kb  did  not  
affect  the  frequency  of  reporter  integration.  One  out  of  16  F0  founders  screened  (6%)  
transmitted  a  precise  5’  junction  through  the  germline,  but  the  3’  junction  could  not  be  amplified  
by  PCR  (Supplementary  Table  3,  4).    
  
Using  the  same  approach,  we  targeted  the  zebrafish  gene  moesina  (msna)  at  exons  2  
and  6,  located  7.8  kb  apart,  with  2A-­Gal4VP16-­b-actin  using  48  bp  of  homology.  This  resulted  
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in  63%  of  embryos  displaying  RFP  in  a  pattern  consistent  with  the  expression  of  msna  (Fig.  5d-­
f,  Supplementary  Table  1,2).  Somatic  junction  fragment  analysis  showed  precise  integration  at  
both  the  5’  (11/13  or  85%  of  the  fragments  analyzed)  and  3’  ends  (9/20  or  45%)  of  msna  
(Supplementary  Fig.  6).  Of  the  10  F0  zebrafish  raised  to  adulthood,  none  transmitted  a  deletion  
tagged  allele  to  the  next  generation.  In  contrast,  targeting  2A-­Gal4VP16-­b-actin  to  exon  2  or  6  
alone  resulted  in  2  out  of  7  F0s  transmitting  a  targeted  allele  to  the  next  generation  
(Supplementary  Table  3,  4).    
  
Together,  these  results  demonstrate  simultaneous  targeting  of  two  distal  genomic  cut  
sites  can  create  integration  at  both  ends  of  a  pGTag  reporter  cassette  by  HMEJ  in  somatic  
tissue,  but  these  events  are  not  easily  passed  through  the  germline.  This  was  reinforced  by  
attempting  deletion  tagging  at  additional  loci,  including  kdrl,  s1pr1,  and  vegfaa,  which  showed  
32-­81%  expression  in  F0s,  but  no  germline  transmission  to  F1s  (Supplementary  Table  2).    
  
Integration  of  Exogenous  DNA  Using  HMEJ  in  Porcine  and  Human  Cells  is  More  Efficient  
than  HR  
   To  determine  if  HMEJ  integration  directed  by  short  homology  functions  efficiently  in  large  
animal  systems,  we  tested  the  GeneWeld  targeting  strategy  in  S.  scrofa  fibroblasts.  The  
ROSA26  safe  harbor  locus  was  targeted  with  a  cassette  that  drives  ubiquitous  eGFP  expression  
from  the  UbC  promoter  (Fig.  6a-­c).  GeneWeld  reagents,  where  the  genomic  sgRNA  was  
replaced  with  mRNAs  encoding  a  TALEN  pair  to  generate  a  genomic  DSB  in  the  first  intron  of  
ROSA26,  were  delivered  to  pig  fibroblasts  by  electroporation.  This  strategy  was  compared  to  
cells  electroporated  with  just  the  TALEN  pair  and  a  HR  donor  containing  approximately  750  bp  
of  homology  flanking  the  genomic  target  site.  GFP  expression  was  observed  in  23%  of  colonies  
using  GeneWeld  reagents,  compared  to  2%  of  colonies  using  the  HR  donor  with  ~750  bp  
homology  arms.  Co-­occurring  precise  5’  and  3’  junctions  were  observed  in  over  50%  of  the  
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GFP+,  GeneWeld  engineered  colonies  while  none  of  the  GFP+,  HR  colonies  contained  both  
junctions.  Sequencing  of  junctions  from  8  GFP+,  GeneWeld  engineered  colonies  that  were  
positive  for  both  junctions  showed  precise  integration  in  7/8  colonies  at  the  5’  junction  and  8/8  
colonies  at  the  3’  junction.    
  
The  GeneWeld  strategy  was  also  used  to  target  integration  of  a  MND:GFP  reporter  
(Halene  et  al.,  1999)  into  the  AAVS1  safe  harbor  locus  in  human  K-­562  cells  (Fig.  6d-­f).  
Integrations  were  attempted  with  either  GeneWeld  reagents  or  an  HR  donor  targeting  the  
AAVS1  cut  site  by  electroporation  of  K-­562  cells.  Cells  were  FACs  sorted  by  GFP  at  day  14  
following  electroporation.  With  GeneWeld  reagents  over  50%  of  cells  were  GFP  positive,  
compared  to  only  6%  of  cells  electroporated  with  the  HR  donor.  This  suggests  the  GeneWeld  
strategy  promoted  efficient  integration  and  stable  expression  of  the  MND:GFP  cassette  at  the  
AAVS1  locus  (Supplementary  Fig.  7).    Expression  was  maintained  over  50  days,  and  5’  precise  
junction  fragments  were  observed  following  PCR  amplification  in  bulk  cell  populations  
(Supplementary  Fig.  8).  The  results  above  demonstrate  that  the  GeneWeld  strategy  





   The  results  described  here  demonstrate  the  utility  of  short  homology-­based  gene  
targeting  for  engineering  precise  integration  of  exogenous  DNA  and  expand  the  potential  of  
efficient  tagging  to  diverse  loci  with  differing  endogenous  expression  levels.  We  show  that  using  
short  homology  to  bridge  distal  ends  together  simultaneously  creates  a  deletion  and  a  reporter  
integration,  however,  these  events  are  not  easily  passed  through  the  germline.    We  
demonstrate  efficient  integration  of  cargos  up  to  approximately  2  kb  in  length  in  zebrafish,  pig  
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fibroblasts,  and  human  cells.  Both  CRISPR/Cas9  and  TALENs  are  effective  as  GeneWeld  
genomic  editors,  providing  flexibility  in  deployment  and  genome-­wide  accessibility.  
  
Several  components  of  the  GeneWeld  strategy  may  lead  to  enhanced  somatic  and  
germline  targeting  efficiencies  in  zebrafish  as  compared  to  previous  reports  (Hisano  et  al.,  
2015).  Canonical  NHEJ  is  highly  active  during  rapid  cell  divisions  in  early  zebrafish  
embryogenesis  (Bedell  et  al.,  2012).  However,  given  the  correct  sequence  context  surrounding  
the  dsDNA  break,  MMEJ  is  the  preferred  method  of  non-­conservative  repair  (Ata  et  al.,  2018;;  
He  et  al.,  2015;;  Kent  et  al.,  2015).  GeneWeld  homology  arms  are  rationally  designed  based  on  
the  known  homology  searching  activity  of  RAD51  and  strand  annealing  activity  of  RAD52  
(Conway  et  al.,  2004;;  Singleton  et  al.,  2002).  In  our  experiments  at  noto,  gene  targeting  is  
significantly  reduced  when  48  bp  homology  arms  are  altered  by  1  bp  to  47  or  49  bp  
(Supplementary  Fig.  3).  This  suggests  that  optimal  short  homology  arms  should  be  designed  in  
groups  of  3  and/or  4  bp  increments.  We  are  currently  testing  this  hypothesis  further.  
Additionally,  Shin  et  al.,  2014  showed  the  highest  rates  of  somatic  targeting  when  their  donor  
was  linearized  in  vitro  inside  a  ~1  kb  5’  homology  arm,  leaving  238  bp  of  homology  flanking  the  
knock-­in  cargo.  Thus,  it  is  tempting  to  speculate  that  gene  targeting  in  these  experiments  
proceeded  not  through  HR,  but  through  other  related  HMEJ  DNA  repair  pathway  more  similar  to  
the  findings  presented  here.    
  
The  dramatic  shift  of  DNA  repair  at  genomic  DSBs  from  cis-­NHEJ  to  trans-­HMEJ  using  
GeneWeld  donors  likely  also  influences  enhanced  editing  of  the  germline.  Across  all  zebrafish  
experiments  with  germline  transmission,  49%  of  founders  transmitted  tagged  alleles,  with  17.4%  
of  gametes  carrying  the  edited  allele  of  interest  (Supplementary  Table  3,  4),  demonstrating  
decreased  germline  mosaicism  and  increased  germline  transmission  from  previous  reports.  
Given  that  our  somatic  knock-­in  and  germline  transmission  rates  are  higher  than  published  
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reports,  we  conclude  that  GeneWeld  is  a  more  effective  homology-­based  method  for  generating  
precisely  targeted  knock-­in  alleles  in  zebrafish.  
  
   While  targeting  noto  with  5’  only  homology  shows  an  increase  in  targeting  efficiency  with  
longer  homology,  increasing  homologies  on  both  ends  of  the  cargo  DNA  did  not  increase  
targeting  efficiency  (Fig.  2e).  Positive  events  are  selected  only  by  fluorescently  tagged  alleles,  
indicating  precise  5’  integration  patterns.  We  speculate  that  inclusion  of  homology  at  the  3’  end  
of  our  cargo  creates  competition  for  the  donor  DNA  ends,  as  not  all  editing  events  are  precise  at  
both  5’  and  3’  junctions  (Fig.  4  and  Supplementary  Fig.  4).  Thus,  it  is  conceivable  that  precise  
events  at  the  3’  end  could  preclude  precise  integration  at  the  5’  end  during  some  editing  events,  
and  vice  versa.  It  is  tempting  to  speculate  that  this  data  hints  at  synthesis  dependent  strand  
annealing  (SDSA)  as  a  possible  DNA  repair  mechanism  for  pGTag  donor  integration  (Ceccaldi  
et  al.,  2016).  After  strand  invasion  using  either  of  the  homology  domains  and  replication  through  
the  reporter,  second  DNA  end  capture  may  abort  before  or  after  replication  through  the  
opposing  homology  domain,  resulting  in  imprecision,  as  greater  than  or  equal  to  150  bp  is  
required  for  proper  second  end  capture  in  yeast  (Mehta  et  al.,  2017).  Experiments  to  address  
this  hypothesis  by  varying  homology  arm  lengths  flanking  the  donor  cassettes  and  including  
negative  selection  markers  are  of  note  for  future  work  in  determining  the  genetic  mechanisms  
that  promote  efficient  integration.  
  
Timing  and  turnover  of  Cas9  during  the  genomic  editing  event  can  influence  cut  
efficiency  and  somatic  mosaicism/germline  transmission  rates  (Clarke  et  al.,  2018;;  Zhang  et  al.,  
2018),  increasing  the  interest  of  using  RNP  during  all  precision  gene  editing  applications.  
However,  we  were  unable  to  observe  fluorescence  following  injection  of  GeneWeld  components  
with  RNPs  or  detect  targeted  integrations  at  a  high  frequency  (unpublished  data).  We  
hypothesize  this  is  due  to  Cas9  and  UgRNA  locating  and  binding  to  the  UgRNA  sites  on  the  
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pGTag  donors  during  dilution  of  the  injection  mixture.  This  heteroduplex  either  activates  DSBs  
on  the  donor  in  vitro,  or  directly  after  injection,  before  the  genomic  gRNA  can  locate  and  cut  the  
genome.  Thus,  the  stochastics  of  DNA  end  availability  are  altered  using  RNPs  and  integration  
activity  is  greatly  reduced.  Injection  of  the  GeneWeld  plasmid  donor  and  RNPs  in  separate  
injection  mixtures  does  not  produce  integration  in  zebrafish  embryos  (unpublished  data).    
Further  experiments  could  address  these  limitations  through  the  use  of  inducible  nuclease  
systems.    
  
Targeting  genes  with  lethal  phenotypes,  such  as  tumor  suppressors  or  other  genes  
required  for  embryogenesis,  is  of  interest  to  the  zebrafish  community.  However,  using  
fluorescence  to  screen  for  targeted  events  can  be  misleading.  For  example,  the  RFP  signal  is  
dramatically  reduced  or  lost  upon  biallelic  inactivation  of  noto,  likely  when  notochord  cells  
transfate  to  muscle  cells  (Melby  et  al.,  1996;;  Talbot  et  al.,  1995).  Additionally,  though  deletion  
tagging  using  two  target  sites  in  the  genome  seems  to  be  robust  in  somatic  tissue,  germline  
transmission  of  deletion  tags  is  rare.  This  suggests  that  edited  germ  cells  may  be  lost  to  
apoptosis  due  to  the  additional  cut  in  the  genome,  or  that  heterozygous  deletion  tagged  alleles  
are  recognized  during  homologous  chromosome  pairing  and  are  repaired  or  lost  as  germ  cells  
mature.  Similar  susceptibility  of  stem  cells  to  apoptosis  following  gene  editing  has  been  
previously  observed  (Ihry  et  al.,  2018;;  Li  et  al.,  2018).  In  both  of  these  cases,  it  may  be  
necessary  to  modulate  GeneWeld  reagent  concentrations  in  order  to  avoid  biallelic  inactivation  
of  the  genomic  target,  or  to  ensure  homozygous  deletion  tagging.    
  
Amplification  of  the  fluorescence  signal  using  GAL4/VP16  allowed  us  to  target  several  
genes  for  which  we  did  not  observe  a  fluorescence  report  from  integration  of  a  fluorescent  
protein  directly.  While  this  approach  is  advantageous  for  selecting  correctly  targeted  embryos  to  
examine  for  germline  integration,  GAL4/VP16  may  have  toxic  effects  as  reported  previously  
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(Ogura  et  al.,  2009).  For  example,  we  found  dominant  phenotypes  in  the  F1  generation  for  both  
msna  and  flna  which  could  reflect  toxicity  from  high  levels  of  expression  of  GAL4/VP16.  
Alternatively,  these  gene  could  also  display  haploinsufficiency  or  express  a  partial  protein  
product  that  functions  in  a  dominant  manner.  Heterozygous  msna  mutants  targeting  exon  5  in  
the  F1  generation  display  phenotypes  similar  to  morpholino  targeting  of  this  gene  (Wang  et  al.,  
2010)  (data  not  shown),  suggesting  haploinsufficiency  or  a  dominant  negative  peptide  is  a  likely  
explanation.    
  
GeneWeld  is  also  an  effective  strategy  to  precisely  control  exogenous  DNA  integration  in  
mammalian  cell  lines.  While  our  data  shows  an  approximate  10-­fold  increase  in  targeted  
integration  using  48  bp  of  homology  to  drive  HMEJ  versus  HR,  Zhang  et  al.  (2017)  concluded  
that  targeted  integration  did  not  appreciably  increase  until  homology  arms  of  ~600  bp  were  used  
(Zhang  et  al.,  2017).  However,  this  could  reflect  differences  in  the  experimental  design  or  cell  
types  used  and  suggest  different  DNA  repair  pathways  may  be  more  prevalent  in  certain  
conditions.  Deciphering  the  DNA  repair  pathway  used  for  HMEJ  in  zebrafish  and  mammalian  
cells  is  paramount  to  increasing  editing  efficiencies  in  basic  research  and  for  gene  therapy.    
  
Given  the  high  efficiency  and  precision  of  GeneWeld,  additional  applications  to  efficiently  
introduce  other  gene  modifications,  such  as  single  or  multiple  nucleotide  polymorphisms,  by  
exon  or  gene  replacement  is  possible  using  the  deletion  tagging  method.  Further,  GeneWeld  
could  be  used  to  create  conditional  alleles  by  targeting  conditional  gene  break  systems  into  
introns  (Clark  et  al.,  2011).  In  conclusion,  our  suite  of  donor  vectors  with  validated  integration  
efficiencies,  methods,  and  web  interface  for  pGTag  donor  engineering  will  serve  to  streamline  
experimental  design  and  broaden  the  use  of  designer  nucleases  for  homology-­based  gene  
editing  at  CRISPR/Cas9  and  TALEN  cut  sites  in  zebrafish.  We  also  demonstrate  an  advanced  
strategy  for  homology-­based  gene  editing  at  CRISPR/Cas9  and  TALEN  cut  sites  in  mammalian  
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Contact  for  reagent  and  resource  sharing  
   Further  information  and  requests  for  resources  and  reagents  should  be  directed  
to  and  will  be  fulfilled  by  the  Lead  Contact,  Jeffrey  Essner  (jessner@iastate.edu).  
  
Experimental  model  and  subject  details  
   Zebrafish  were  maintained  in  Aquatic  Habitats  (Pentair)  housing  
on  a  14  hour  light/10  hour  dark  cycle.  Wild-­type  WIK  were  obtained  from  the  Zebrafish  
International  Resource  Center.  The  Tg(miniTol2/14XUAS:mRFP,  γCry:GFP)tpl2,  shortened  
to  Tg(UAS:mRFP)tpl2,  was  previously  described  (Balciuniene  et  al.,  2013).  All  experiments  were  
carried  out  under  approved  protocols  from  Iowa  State  University  IACUC.      
  
   The  human  K-­562  chronic  myelogenous  leukemia  cell  line  (ATCC  CCL-­243)  used  in  
gene  targeting  experiments  was  cultured  at  37oC  in  5%  CO2  in  RPMI-­1640  (Thermo  Fisher  
Scientific)  supplemented  with  10%  fetal  bovine  serum  (FBS)  and  
Penicillin/Streptomycin.    Electroporation  was  conducted  with  1.5  x  105  cells  in  a  10  µl  tip  using  
the  Neon  electroporation  device  (Thermo  Fisher  Scientific)  with  the  following  conditions:  1450V,  
10ms,  3x  pulse.  Nucleic  acid  dosages  were  as  follows:  1.5  µg  Cas9  mRNA  
(Trilink  Biotechnologies),  1  µg  each  chemically  modified  sgRNA  (Synthego),  and  1  µg  donor  
plasmid.  
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   Fibroblasts  were  cultured  in  DMEM  (high  glucose)  supplemented  to  10%  vol/vol  FBS,  20  
mM  L-­glutamine  and  1X  Pen/  Strep  solution  and  transfected  using  the  NeonTM  system  
(Invitrogen).    Briefly,  1  x  106  fibroblasts  were  transfected  with  1  ug  of  polyadenylated  ROSA  
TALEN  mRNA,  1  µg  of  universal  gRNA  mRNA,  1  µg  of  polyadenylated  Cas9  mRNA  and  1  µg  of  
donor  plasmid.    Transfected  cells  were  cultured  for  3  days  at  30oC  before  low  density  plating,  
extended  culture  (10  days)  and  colony  isolation.    Individual  colonies  were  aspirated  under  
gentle  trypsanization,  replated  into  96-­  well  plates  and  cultured  for  3-­4  days.    
  
pGTag  series  vectors      
To  build  the  pGTag  vector  series,  2A-­TagRFP,  2A-­eGFP,  and  2A-­Gal4/VP16  
cassettes  were  assembled  from  a  2A-­TagRFP-­CAAX  construct,  p494.  To  clone  
the  eGFP  cassette,  the  plasmid  p494  was  amplified  with  primers  F-­p494-­XhoI  and  R-­p494-­SpeI  
to  generate  unique  enzyme  sites  in  the  backbone.  The  eGFP  coding  
sequence  (Clontech  Inc.)  was  amplified  with  the  primers  F-­eGFP-­SpeI  and  R-­eGFP-­XhoI  to  
generate  the  corresponding  enzyme  sites  on  the  eGFP  coding  sequence.  Fragments  
were  digested  with  SpeI-­HF  and  XhoI  (NEB)  and  following  column  purification  with  the  Qiagen  
miniprep  protocol,  were  ligated  to  the  plasmid  backbone  with  T4  ligase  (Fisher).        
    
The  Gal4/VP16  coding  sequence  and  zebrafish  b-­actin  3’  untranslated  region  was  
amplified  from  vector  pDB783  (Balciuniene  et  al.,  2013)  with  primers  F-­2A-­Gal4-­BamHI  and  R-­
Gal4-­NcoI  to  add  a  2A  peptide  to  the  5’  end  of  the  Gav4Vp16  cDNA.  The  resulting  PCR  product  
was  then  cloned  into  the  intermediate  Topo  Zero  Blunt  vector  (Invitrogen)  and  used  for  
mutagenesis  PCR  with  primers  F  and  R  ‘-­gal4-­Ecofix’  to  disrupt  the  internal  EcoRI  restriction  
site.  The  resulting  Gal4/VP16  sequence  was  cloned  into  the  BamHI  and  NcoI  sites  in  the  p494  
backbone.      
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The  5’  universal/optimal  guide  site  and  lacZ  cassette  were  added  to  pC-­2A-­TagRFP-­
CAAX-­SV40,  pC-­2A-­eGFP-­SV40,  and  pC-­2A-­Gal4VP16-­b-­actin  with  the  following  steps.  
The  lacZ  was  first  amplified  with  primers  F-­lacZ  and  R-­lacZ,  which  add  the  type  IIS  enzyme  
sites  to  either  end  of  the  lacZ.  The  resulting  PCR  product  was  then  cloned  into  an  intermediate  
vector  with  the  Zero  Blunt®  TOPO®  PCR  Cloning  Kit  (Invitrogen).  This  intermediate  was  used  
as  a  template  in  a  nested  PCR  to  add  the  Universal  
guide  sequence  GGGAGGCGTTCGGGCCACAGCGG  to  the  end  of  the  lacZ  
sequence.  The  nested  PCR  used  primers  F-­lacZ-­universal-­1  and  R-­lacZ-­universal-­BamHI  to  
add  the  first  part  of  the  universal  guide  to  one  end  and  a  BamHI  site  to  the  other.    This  was  used  
as  template  for  PCR  with  the  primers  F-­lacZ-­universal-­EcoRI  and  R-­lacZ-­universal-­BamHI  to  
add  the  remainder  of  the  universal  guide  and  an  EcoRI  site.  The  fragment  was  column  purified  
as  above,  digested  with  EcoRI-­HF  and  BamHI-­HF  and  cloned  into  the  appropriate  sites  in  the  
three  vectors.      
    
The  3’  universal  guide  and  type  2  restriction  enzyme  sites  were  cloned  into  each  
vector  in  two  steps.  A  segment  from  a  Carp  beta-­actin  intron  containing  a  99  bp  spacer  flanked  
by  two  BspQI  sites  was  amplified  using  the  primers  F-­3’-­uni-­1  and  R-­3’-­uni-­1  to  add  the  
universal  site  to  one  side  of  the  spacer.  This  product  was  column  purified  as  above  and  used  as  
template  for  the  second  amplification  with  primers  F-­3’-­uniNco1  and  R-­3’-­uniEagI  to  add  cloning  
sites.  This  product  was  column  purified  and  cloned  using  the  Topo  zero  blunt  kit.  This  
intermediate  was  digested  with  NcoI-­HF  and  EagI,  and  the  BspQI  fragment  purified  and  cloned  
into  the  three  vectors  as  above.    Ligations  were  grown  at  30oC  to  reduce  the  possibility  of  
recombination  between  the  two  universal  guide  sites.      
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Correct  clones  for  pU-­2A-­TagRFP-­CAAX-­U,  pU-­2A-­eGFP-­U,  and  pU-­2A-­Gal4/VP16-­
U  were  selected  and  used  as  template  for  mutagenesis  PCR  with  KOD  to  remove  
extra  BspQI  sites  from  the  backbone  with  primers  F/R-­BBfix,  digested  
with  DpnI  (NEB),  and  ligated  with  T4  ligase.  A  correct  pU-­2A-­TagRFP-­CAAX-­U  clone  was  used  
as  template  for  PCR  with  F/R-­TagRFPfix  to  interrupt  the  BspQI  site  in  the  TagRFP  coding  
sequence  as  above.  A  correct  clone  of  pU-­2A-­Gal4/VP16-­U  was  selected  and  used  as  template  
with  primers  F/R-­Bactfix  to  remove  the  BspQI  site  in  the  Beta-­actin  terminator,  the  product  was  
re-­cloned  as  above.  All  constructs  were  sequence  verified.      
  
Homology  arm  design  and  donor  vector  construction      
For  detailed  methods,  see  Supplementary  gene  targeting  protocol.  In  brief,  
homology  arms  of  specified  length  directly  flanking  a  genomic  targeted  double  strand  
break  were  cloned  into  the  pGTag  vector,  in  between  the  UgRNA  sequence  and  the  cargo.  
A  three  nucleotide  buffer  sequence  lacking  homology  to  the  genomic  target  site  was  engineered  
between  the  donor  UgRNA  PAM  and  the  homology  arms,  in  order  to  maintain  the  specified  
homology  arm  length.  See  Supplementary  Table  4  for  all  homology  arms,  gRNA  target  sites,  
and  spacers.      
    
Zebrafish  embryo  injection    
pT3TS-­nCas9n  was  a  gift  from  Wenbiao  Chen  (Addgene  plasmid  #  
46757).  XbaI  linearized  pT3TS-­nCas9n  was  purified  under  RNase-­free  conditions  with  the  
Promega  PureYield  Plasmid  Miniprep  System.  Linear,  purified  pT3TS-­nCas9n  was  used  as  
template  for  in  vitro  transcription  of  capped,  polyadenylated  mRNA  
with  the  Ambion  T3TS  mMessage  mMachine  Kit.  mRNA  was  purified  using  
Qiagen  miRNeasy  Kit.  The  genomic  and  universal  sgRNAs  were  generated  using  cloning  
free  sgRNA  synthesis  as  described  in  (Varshney  et  al.,  2015)  and  purified  using  
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Qiagen  miRNeasy  Kit.  Donor  vector  plasmid  DNA  was  purified  with  the  
Promega  PureYield  Plasmid  Miniprep  System.  noto,  cx43.4,  tyrosinase,  and  moesina,  were  
targeted  by  co-­injection  of  150  pg  of  nCas9n  mRNA,  25  pg  of  genomic  sgRNA,  
25  pg  of  UgRNA  (when  utilized),  and  10  pg  of  donor  DNA  diluted  in  RNAse  free  
ddH2O.  The  rb1  targeting  mixture  contained  300  pg  nCas9n  mRNA.  2  nl  was  delivered  to  each  
embryo.      
    
Recovery  of  zebrafish  germline  knock-­in  alleles    
Injected  animals  were  screened  for  fluorescence  reporter  expression  on  a  Zeiss  
Discovery  dissection  microscope  and  live  images  captured  on  a  Zeiss  LSM  700  laser  scanning  
confocal  microscope.  RFP/GFP  positive  embryos  were  raised  to  adulthood  and  outcrossed  to  
wildtype  WIK  adults  to  test  for  germline  transmission  of  fluorescence  in  F1  
progeny.  tyr,  esama,  rb1  and  msna  embryos  targeted  with  Gal4VP16  were  crossed  
to  Tg(UAS:mRFP)tpl2.      
    
DNA  isolation  and  PCR  genotyping    
Genomic  DNA  for  PCR  was  extracted  by  digestion  of  single  embryos  in  50mM  NaOH  at  
95oC  for  30  minutes  and  neutralized  by  addition  of    1/10th  volume  1M  Tris-­HCl  pH  8.0.  Junction  
fragments  were  PCR-­amplified  with  primers  listed  in  Supplementary  Table  X  and  the  
products  TOPO-­TA  cloned  before  sequencing.    
    
Southern  blot  analysis    
Genomic  Southern  blot  and  copy  number  analysis  was  performed  as  described  
previously  (McGrail  et  al.,  2011).  PCR  primers  used  for  genomic  and  donor  specific  probes  are  
listed  in  Supplementary  Table  6.    
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Junction  fragment  analysis  in  pig  fibroblasts    
Individual  colonies  were  scored  for  GFP  expression  and  prepared  for  PCR  by  washing  
with  1X  PBS  and  resuspension  in  PCR-­safe  lysis  buffer  (10  mM  Tris-­Cl,  pH  8.0;;  2  mM  EDTA;;  
2.5%  (vol/vol)  Tween-­20;;  2.5%  (vol/vol)  Triton-­X  100;;  100  μg/mL  Proteinase  K  followed  by  
incubation  at  50oC  for  60  min  and  95oC  for  15  min.    PCR  was  performed  using  
1X  Accustart  Supermix  (Quanta)  with  the  primers:  5’  junction  F-­5’  
TAGAGTCACCCAAGTCCCGT-­3’,  R-­5’-­  ACTGATTGGCCGCTTCTCCT-­3’;;  3’  junction  F-­5’-­  
GGAGGTGTGGGAGGTTTTT-­3’,  R-­5’-­  TGATTTCATGACTTGCTGGCT-­3’.  ROSA  TALEN  
sequences  are:    TAL  FNG  NI  NI  HD  HD  NG  NN  NI  NG  NG  HD  NG  NG  NN  NN;;  TAL  RHD  NN  
NG  NI  HD  NI  HD  HD  NG  NN  HD  NG  HD  NI  NI  NG.    
    
K-­592  Flow  Cytometry    
K-­562  cells  were  assessed  for  GFP  expression  every  7  days  for  28  days  following  
electroporation.  Flow  cytometry  was  conducted  on  an  LSRII  instrument  (Becton  Dickinson)  and  
data  was  analyzed  using  FlowJo  software  v10  (Becton  Dickinson).  Dead  cells  were  excluded  
from  analysis  by  abnormal  scatter  profile  and  exclusion  based  on  Sytox  Blue  viability  dye  
(Thermo  Fisher  Scientific).      
    
Junction  PCR  to  detect  targeted  integration  was  conducted  using  external  genomic  
primers  outside  of  the  48bp  homology  region  and  internal  primers  complementary  to  the  
expression  cassette.  PCR  was  conducted  using  Accuprime  HIFI  Taq  (Thermo  Fisher  Scientific).  
PCR  products  from  bulk  population  were  sequenced  directly.      
  
Quantification  and  statistical  analysis  
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   Statistical  analysis  was  performed  using  GraphPad  Prism  software.  Data  plots  represent  
mean  +/-­  s.e.m.  of  n  independent  experiments,  indicated  in  the  text.  p  values  were  calculated  
with  two-­tailed  unpaired  t-­test.  Statistical  parameters  are  included  in  the  figure  legends.  
  
Data  and  software  availability    
   The  webtool  GTagHD    was  developed  to  assist  users  in  designing  oligonucleotides  for  
targeted  integration  using  the  pGTag  vector  suite.  GTagHD  guides  users  through  
entering:  1)  the  guide  RNA  for  cutting  their  cargo-­containing  plasmid;;  2)  the  guide  RNA  for  
cutting  their  genomic  DNA  sequence;;  (3)  the  genomic  DNA  sequence,  in  the  form  of  
a  GenBank  accession  number  or  copy/pasted  DNA  sequence;;  and  4)  the  length  of  
microhomology  to  be  used  in  integrating  the  plasmid  cargo.  If  the  user  is  utilizing  one  of  
the  pGTag  series  plasmids,  GTagHD  can  also  generate  a  GenBank/ApE  formatted  file  for  that  
plasmid,  which  includes  the  user's  incorporated  oligonucleotide  sequences.  GTagHD  is  freely  
available  online  at  http://genesculpt.org/gtaghd/  and  for  download  at  https://github.com/Dobbs-­
Lab/GTagHD.    
  
Key  resources  table  
  
REAGENT  or  RESOURCE   SOURCE   IDENTIFIER  
Antibodies  
Bacterial  and  Virus  Strains    
NEB  Stable  Competent  E.  coli   NEB   CAT#C3040I  
One  Shot  TOP10  Chemically  Competent  E.  coli   ThermoFisher   CAT#C404010  
Biological  Samples        
Chemicals,  Peptides,  and  Recombinant  Proteins  
Critical  Commercial  Assays  
pCR4  TOPO  TA  Cloning  Kit  for  Sequencing   ThermoFisher   CAT#K457502  
Deposited  Data  
Experimental  Models:  Cell  Lines  
Human:  K562  cell  line   ATCC   CAT#  ATCC  CCL-­
243  
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Porcine:  Fibroblast  cell  line   Recombinetics,  Inc.   Recombinetics,  Inc.  
Experimental  Models:  Organisms/Strains  
Zebrafish:  WIK  strain   ZIRC   CAT#ZL84  
Zebrafish:  pDB790   Balciunas  Lab   Upon  request  
Oligonucleotides  
See  Supplementary  table  6  for  all  primers  used     This  paper   N/A  
Recombinant  DNA  
p494-­2a-­TagRFP-­CAAX-­SV40   This  paper   To  be  deposited  at  
AddGene  
pGTag-­2A-­TagRFP-­CAAX-­SV40   This  paper   To  be  deposited  at  
AddGene  
pGTag-­2A-­Gal4VP16-­bactin   This  paper   To  be  deposited  at  
AddGene  
pGTag-­2A-­eGFP-­SV40   This  paper   To  be  deposited  at  
AddGene  
Software  and  Algorithms  
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Figure  1.  GeneWeld  strategy  and  pGTag  vector  series  (a)  GeneWeld  reagent  components  
are  designed  for  simultaneous  genome  and  donor  nuclease  targeting  to  reveal  short  regions  of  
homology.  Red  arrowheads  represent  in  vivo  designer  nuclease  DSBs.  Components  include:  1  -­  
Designer  nuclease  mRNA,  either  Cas9  to  target  both  the  genome  and  donor,  or  Cas9  to  target  
the  donor  and  TALEN  to  cut  the  genome;;  2  -­  sgRNA  for  targeting  Cas9  to  genome;;  3  -­  Universal  
sgRNA  to  liberate  donor  cargo  and  homologous  ends;;  and  4  -­  pGTag  donor  of  interest  with  
short  homology  arms.  (b)  Type  IIs  restriction  endonucleases  BfuAI  and  BspQI  create  
incompatible  ends  outside  of  their  recognition  sequence,  allowing  digestion  and  ligation  of  both  
homology  arms  into  the  vector  in  a  single  reaction.  Homology  arm  fragments  are  formed  by  
annealing  complementary  oligonucleotides  to  form  dsDNA  with  sticky  ends  for  directional  
cloning  into  the  vector.  XFP  =  Green  or  Red  Fluorescent  Protein.  pA  =  SV40  or  β-­actin  3’  
untranslated  region.  Red  and  green  fluorescent  proteins  were  cloned  into  the  pGTag  vectors,  
and  for  each  color,  subcellular  localization  sequences  for  either  nuclear  localization  (NLSs)  and  
membrane  localization  (CAAX)  are  provided  (c)  Schematic  of  GeneWeld  targeting  in  vivo.  After  
designer  nuclease  creates  targeted  double-­strand  breaks  in  the  genome  and  donor,  end  
resection  likely  precedes  homology  recognition  and  strand  annealing,  leading  to  integration  of  
the  donor  without  vector  backbone.  Red  arrowheads  represent  in  vivo  designer  nuclease  DSBs.    
  
Figure  2.  HMEJ  strategy  promotes  efficient  somatic  targeting  of  knock-­in  cassettes  at  
different  zebrafish  loci.  (a-­d)  Live  confocal  images  of  F0  injected  embryos  showing  fluorescent  
reporter  expression  of  noto-­2A-­eGFP-­SV40  at  mid  somite  stage  (a,  a’),  cx43.4-­2A-­tagRFP-­
CAAX-­SV40  at  31  hours  post  fertilization  (b,  b’).  Expression  from  UAS-­RFP  Tg(UAS:mRFP)tpl2  
after  injection  with  tyr-­2A-­Gal4VP16-­β-­actin  at  5  days  post  fertilization  (dpf)  (c,  c’),  or  esama-­2A-­
Gal4VP16-­β-­actin  at  2  dpf  (d)  and  3  dpf  (d’).  (e)  Reporter  gene  expression  following  targeting  
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with  HMEJ  at  noto,  cx43.4,  tyr,  and  esama  results  in  a  high  proportion  of  injected  F0  embryos  
displaying  widespread  signals.  Homology  lengths  flanking  donor  cargos  indicated  by  24/24  or  
48/48,  in  base  pairs.  Data  represents  mean  +/-­  s.e.m.  of  3  independent  targeting  experiments.  
Scale  bars,  100  µm.  
  
Figure  3.  Live  confocal  images  of  F1  zebrafish  with  inherited  germline  alleles  of  
integrated  GTag  reporters.    (a,  a’)  Tg(noto-­2A-­TagRFP-­CAAX-­SV40)  embryo  at  mid  somite  
stage  showing  expression  in  the  notochord  and  floor  plate.  (b,  b’)  Tg(tyr-­2A-­Gal4Vp16-­β-­actin)  
displaying  expression  in  the  melanocytes  in  a  5  dpf  larva.  (c,  c’)  Tg(esama-­2A-­Gal4Vp16-­  β-­
actin)  larva  showing  expression  in  the  vascular  system  at  4  dpf.  (d,  d’)  Tg(flna-­2A-­Gal4VP16-­  β-­
actin)  embryo  at  1  dpf  showing  widespread  expression.  (e,  e’  and  f,  f’)  Tg(msna-­2A-­Gal4VP16-­  
β-­actin)  targeted  to  either  exon  2  or  exon  6  showed  expression  in  the  central  nervous  system  
and  vasculature  at  2  dpf.  (g,  g’  and  h,  h’)  Tg(aqp1a1-­2A-­Gal4VP16-­  β-­actin)  and  Tg(aqp8a1-­2A-­
Gal4VP16-­  β-­actin)  display  expression  in  the  trunk  and  tail  vasculature  at  2  dpf.  All  images  are  
lateral  views,  and  the  Gal4VP16  integrations  have  Tg(UAS:mRFP)tpl2  in  the  background  for  
visualization  of  expression.  Scale  bars  are  100  µm.    
  
Figure  4.  Molecular  analysis  of  F1  embryos  from  gene  targeting  experiments  at  noto  and  
tyr.  (a-­c)  Tg(noto-­2A-­RFP)  F1  targeted  integration  alleles  from  2  independent  F0  founders.  (a)  
noto  gene  model  with  location  of  restriction  enzymes  used  for  genomic  Southern  blot  analysis.  
Location  of  the  513  bp  noto  probe  is  indicated  (dark  lines).  The  predicted  and  recovered  alleles  
are  shown.  (b)  Southern  blots  of  F1  Tg(noto-­2A-­RFP)  individuals  hybridized  with  RFP  probe.  F1  
from  founder  F0#1  contain  a  ~2100  bp  band  corresponding  to  integration  plus  deletion  of  ~400  
bp  in  noto.  F1  progeny  from  founder  F0#2  show  two  bands:  a  ~3700  bp  band  corresponding  to  
integration  of  the  reporter  plus  2000  bp  of  vector  backbone,  and  a  ~1500  bp  band  which  may  
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represent  an  off-­target  integration.  Loading  controls  (10,  1)  correspond  to  10  copies  or  1  copy  of  
RFP  containing  plasmid.  WIK,  wild  type  control  DNA.  (c)  Southern  blot  in  (b)  stripped  and  re-­
hybridized  with  the  noto-­specific  probe.  A  1342  bp  band  representing  the  wild  type  allele  was  
detected  in  all  individuals.  The  integration  allele  in  F1s  from  F0  #1  was  not  detected  due  to  
deletion  of  the  region  containing  the  probe.  F1s  from  F0  #2  contain  the  ~3700  bp  band  
corresponding  to  the  noto-­2A-­RFP  integration  allele.  (d,  e)  Molecular  analysis  of  Tg(tyr-­2A-­
GAL4/VP16)  F1  offspring  from  a  single  targeted  F0  founder.  (d)  Schematic  of  expected  
integration  pattern  for  tyr  targeted  with  pGTag-­2A-­GAL4/VP16.  148  bp  tyr  probe  in  Exon  3  and  
583bp  probe  in  GAL4/VP16  are  indicated.  (e)  GAL4/VP16  and  (f)  tyr  probed  Southern  blots  of  
genomic  DNA  from  wild  type  (WIK)  and  4  individual  GAL4/VP16  positive  F1s.  The  expected  
7400  bp  band  is  detected  with  both  probes,  suggesting  a  single  copy  integration.  
  
Figure  5.  Deletion  tagged  alleles  created  with  the  HMEJ  strategy  during  zebrafish  
embryogenesis.  (a)  Schematic  for  Gal4VP16  reporter  integration  to  tag  a  deletion  allele  of  rb1  
exons  2-­4  (top)  and  rb1  exons  2-­25  (bottom).  Arrowheads  designate  CRISPR/Cas9  DSBs.  
CRISPR  gRNAs  in  two  exons  are  expected  to  liberate  the  intervening  genomic  DNA.  The  
targeting  vector  to  replace  the  liberated  genomic  sequence,  contains  a  5’  homology  arm  to  the  
upstream  exon  and  a  3’  homology  arm  to  the  downstream  exon  inside  of  uGuide  sites.  (b,  b’)  
Live  confocal  image  of  F0  Tg(UAS:mRFP)tpl2  embryo  deletion  tagged  at  rb1  exons  2-­4,  and  (c,  
c’)  deletion  tagged  at  rb1  exons  2-­25  by  integration  of  2A-­Gal4VP16-­β-­actin  .  (d)  Schematic  for  
Gal4VP16  deletion  tagging  of  msna  exons  2-­6.  (e,  e’)  Live  confocal  image  of  F0  
Tg(UAS:mRFP)tpl2  embryo  deletion  tagged  at  msna  exons  2-­6  with  2A-­Gal4VP16-­β-­actin.  (f)  
Somatic  reporter  efficiency of  targeted  deletion  tagging  using  48  bp  homology  arms  for  rb1  
exons  2-­4,  rb1,  exons  2-­25  and  msna  exons  2-­6.  Data  represents  mean  +/-­  s.e.m.  of  4  (rb1)  and  
5  (msna)  independent  targeting  experiments.  Scale  bars  in  b,  c,  c’,  e  are  200  µm  and    b’,  e’  are  
100  µm.  
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Figure  6.  HMEJ-­based  targeted  integration  with  UgRNA-­based  vectors  promotes  efficient  
knock-­in  in  porcine  fibroblasts  and  human  K-­562  cells.  (a)  Strategy  for  integration  using  
HMEJ  and  HR  donors  into  intron  1  of  S.  scrofa  ROSA26  locus.  Arrow  heads  CRISPR/Cas9  (for  
HMEJ  donor)  and  TALEN  (genome)  DSBs.  (b)  Targeting  efficiency  of  the  HMEJ  donor  vs  the  
HR  donor  as  reported  by  GFP  positive  colonies  out  of  total  colonies.  (c)  Percent  of  GFP  positive  
colonies  analyzed  containing  properly  sized  junction  fragments,  comparing  HMEJ  and  HR  
donors.  Data  are  from  three  independently  targeted  cell  populations.  Data  represents  mean  +/-­  
s.e.m.  of  3  independent  targeting  experiments.  (d)  Diagram  of  HR  and  HMEJ  strategies  for  
targeted  integration  of  a  MND:GFP  reporter  cassette  into  the  human  AAVS1  locus.  (e)  Flow  
cytometry  analysis  of  GFP  expression  14  days  post-­electroporation  for  each  targeting  modality:  
HR  (left),  HMEJ  without  universal  sgRNA  (middle),  and  HMEJ  with  universal  sgRNA  (right).  
Stable  gate  was  drawn  to  measure  the  uniformly  expressing  population  formed  by  targeted  
integration  and  was  set  based  on  episome  only  controls.  (f)  Quantitation  of  stable  GFP  
expressing  population  as  measured  by  flow  cytometry  at  day  14.  Data  are  from  three  
independently  targeted  cell  populations.  Data  represents  mean  +/-­  s.e.m.  of  3  independent  
targeting  experiments.  p  values  calculated  using  two-­tailed  unpaired  t-­test.  
  
Supplementary  Figure  1.  Short  homology  to  the  noto  gene  from  a  single  homology  arm  5’  
to  the  gRNA  target  site  targets  integration  in  zebrafish  embryos.  (a)  Schematic  for  noto  
homology  arm  and  donor  vector  design.  gRNA  is  the  noto  non-­coding  template  strand.  Black  
bars  represent  12,  24,  and  48  bp  homology  arms.  PAM  sequences  are  underlined.  (b)  Targeting  
efficiency  of  12,  24,  and  48  bp  noto  5’  only  donors.  Data  represents  mean  +/-­  s.e.m.  of  3  
independent  targeting  experiments.  p  values  calculated  using  two-­tailed  unpaired  t-­test.  (c)  Live  
confocal  image  of  noto-­2A-­TagRFP-­CAAX-­SV40  targeted  embryo  showing  specific  RFP  
expression  in  the  notochord.  Scale  bar  is  100  µm.  (d)  Sanger  sequencing  of  cloned  5’  junction  
.CC-BY-NC 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/431627doi: bioRxiv preprint first posted online Oct. 3, 2018; 
Wierson,  Welker  et  al.  GeneWeld:  a  method  for  efficient  targeted  integration  directed  by  short  homology  
 30  
fragments  from  RFP  positive  F0  embryos,  aligned  to  the  expected  sequence  from  a  precise  
integration  event.  
  
Supplementary  Figure  2.  Single  base  pair  differences  in  homology  arm  length  5’  to  the  
Cas9/gRNA  cut  site  influence  integration  frequencies  in  zebrafish  embryos.  (a)  Schematic  
for  targeting  2A-­TagRFP-­CAAX-­SV40  into  noto  exon  1  with  5’  homology  to  the  Cas9/gRNA  cut  
site  containing  47,  48,  or  49  bp  of  homology.  (b)  The  frequency  of  injected  zebrafish  embryos  
displaying  notochord  RFP  expression  after  targeting  noto  exon  1  with  donors  containing  47,  48,  
or  49  bp  of  5’  homology.  Data  represents  mean  +/-­  s.e.m.  of  3  (47  bp,  49  bp)  or  7(48  bp)  
independent  targeting  experiments.  p  values  calculated  using  two-­tailed  unpaired  t-­test.  
  
Supplementary  Figure  3.  The  Universal  gRNA  (UgRNA)  promotes  high  efficiency  targeted  
integration.  (a)  Universal  gRNA  (UgRNA)  sequence.  Cas9  PAM  underlined.  (b)  Schematic  
showing  the  sequence  of  UgRNA  in  the  targeting  domain  of  the  knock-­in  cassette.  Sequence  in  
green  from  the  noto  gene  is  the  engineered  homology  in  the  donor  vector  for  HMEJ.  The  Cas9  
PAM  is  underlined.  (b)  Frequency  of  injected  embryos  displaying  RFP  expression  in  the  
notochord  compared  to  total  injected  embryos  following  noto  targeting  using  UgRNA  to  liberate  
the  homology  in  the  donor.  
  
Supplementary  Figure  4.  Sequence  of  PCR  junction  fragments  amplified  from  F1  genomic  
DNA  show  precise  integrations  at  the  5’  and  3’  ends  of  most  F1s.  Lowercase  letters  represent  
“padding”  nucleotides  used  to  bring  homology  in  frame  of  the  coding  region  based  on  Cas9  cut  
site.  Red  letters  represent  mismatches  unless  otherwise  noted  below.  Underline  represents  the  
up-­  and  downstream  sequence  after  homology  arms  and  precise  integration  confirmation.  Cross  
through  is  an  imprecise  insertion.  esama  F1  3’  junctions  –  Red  T  in  all  samples  was  included  in  
homology  arms  as  an  annotated  synonymous  variant  per  Ensembl.  
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Supplementary  Figure  5.  Integration  of  Gal4/VP16  amplifies  signal  of  targeted  tyr.  (a)  PCR  
of  5’  junction  fragments  and  sequencing  results  from  junction  fragments  between  the  pGTag  
vector  and  the  tyr  locus  amplified  from  randomly  selected  RFP  negative  embryos  after  injection  
with  GeneWeld  reagents  for  targeting  tyr  with  2A-­tagRFP-­CAAX-­SV40pA.  Most  F0  injected  
zebrafish  contain  the  expected  5’  junction  fragment  (marked  with  an  ‘*’).  The  junction  fragments  
from  F0-­1  and  -­2  were  isolated  for  sequencing,  and  precise  integrations  were  observed  (b)  
Efficiency  of  5’  homology  integration  to  target  RFP  or  GAL4/VP16  into  tyr  and  detect  RFP  
expression.  Data  represents  mean  +/-­  s.e.m.  of  3  independent  targeting  experiments.  p  values  
calculated  using  two-­tailed  unpaired  t-­test.  
  
Supplementary  Figure  6.  Sequences  of  5’  and  3’  junction  fragments  from  rb1  exon  2-­4,  
rb1  exon  2-­25,  and  msna  exon  2-­6  deletion  tagged  alleles  in  F0  injected  embryos.  
Primarily  precise  junction  fragments  at  the  5’  and  3’  ends  are  recovered  in  somatic  tissue  of  F0  
targeted  embryos.  Cloned  PCR  amplicons  were  sequenced  from  3  individual  embryos  for  each  
targeted  deletion  tagging  experiment.  
  
Supplementary  Figure  7.  HMEJ-­mediated  targeted  integration  of  an  MND:GFP  reporter  at  
the  AAVS1  locus  in  human  K-­562  cells.  FACs  sorted  percent  of  GFP+  cells  out  of  total  K-­562  
cells  at  day  7,  21,  28,  and  50.  (b)  Summary  data  for  percent  of  stable  GFP+  K-­562  cells  from  
day  7,  14,  21,  and  28.  (b’)  Summary  data  for  percent  of  total  cells  GFP+  from  day  7,  14,  21,  28,  
and  50.  Data  represents  mean  +/-­  s.e.m.  of  3  independent  targeting  experiments.  p  values  
calculated  using  two-­tailed  unpaired  t-­test.  
  
Supplementary  Figure  8.  Direct  sequencing  of  5’  junction  PCR  products  derived  from  
three  independently  targeted  bulk  cell  populations.  (a)  Direct  sequencing  of  5’  junction  PCR  
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products  derived  from  three  independently  targeted  bulk  cell  populations.  48  bp  HMEJ  
homology  region  and  remainder  of  genomic  AAVS1  gRNA  are  indicated.  Genomic  sequence  is  
directly  left  of  the  48  bp  HMEJ  region  and  vector  sequence  is  directly  to  the  right  of  the  AAVS1  
gRNA  cut  site.  
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12 base pair homology arm
                    noto  <  12 bp  > 2A
Precise junction – ACCAACCAAACGCCTGTCGGATCC
Emb. 1 allele 1  - ACCAACCAAACGCCTGTCGGATCC  1/5 clones 
Emb. 1 allele 2  - ACCAACCAAACGCCTGTCAGGATCC 4/5 clones
Emb. 2 allele 1  - ACCAACCAAACGCCTGTCGGATCC  4/4 clones
                                       Total 5/9 clones
24 base pair homology arm
                    noto <---      24 bp    ---> 2A
Precise junction – TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
Emb. 1 allele 1  - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC 10/10 clones                          
Emb. 2 allele 1  - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC 9/10 clones
Emb. 2 allele 2  - TACCGGAGCATAACCAACCAAACGCCTGTCTAGGAGCATAACCAACCAAACGCCTGTCGGATCC 1/10 clones
                                                                             Total 19/20 clones
48 base pair homology arm
                    noto <-------------        48 bp      -------------> 2A
Precise junction – GAGATGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
Emb. 1 allele 1  - GAGATGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATCC  5/9 clones
Emb. 1 allele 2  - GAGATGAGAGAAGAGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATCC 4/9 clones
Emb. 2 allele 1  - GAGATGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATCC  9/10 clones
Emb. 2 allele 2  - GAGATGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTCGGATTC  1/10 clones























****, p-value < 0.0001 
***, p value 0.0002
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noto F1 junction fragments from DNA represented on 
Southern Blot
24 base pair homology arms -
5’ F1 junctions from F0 #1 
                    noto  <---  24 bp domain  --->Vector
Precise junction – TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
F1 #1            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
F1 #2            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
F1 #3            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
F1 #4            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
3’ F1 junctions from F0 #1
                     --24bp homology domain--      Alternate  homology
Knock-in alignment - TCCAGCTCTGCGCTCCCGCTTATT------ATCTGCTCTCCAACTCACT
F1 #1 no sequencing performed
F1 #2              - TCCAGCTCTGCGCTCCCGCTTATTCCGCTTATCTGCTCTCCAACTCACT
F1 #3              - TCCAGCTCTGCGCTCCCGCTTATTCCGCTTATCTGCTCTCCAACTCACT
F1 #4              - TCCAGCTCTGCGCTCCCGCTTATTCCGCTTATCTGCTCTCCAACTCACT
5’ F1 junctions from F0 #2
                    noto  <---  24 bp domain  --->Vector
Precise junction – TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
F1 #5            - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
F1 #6            - TACCGGAGCATAACCAACCAAACGcCTGTCGGATCC
F1 #7            - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
F1 #8            - TACCGGAGCATAACCAACCAAACGCCTGTCGGATCC
3’ F1 junctions from F0 #2
No junctions obtained
tyr F1 junction fragments - DNA from single F1
24 base pair homology arms -
5’ F1 junction  
                     Tyr <---  24 bp domain  --->  Vector
Precise junction – ACAACGACGGATACTTCATGGTGCCCTTCAttGGATCC
F1               - ACAACGACGGATACTTCATGGTGCCCTTCAttGGATCC
3’ F1 junction
                   Vector<---  24 bp domain  ---> Tyr
Precise junction - CCATGGTCCCTCTCTACAGGAACGGAGACTATTTTC
F1               - CCATGGTCCCTCTCTACAGGAACGGAGACTATTTTC
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esama F1 junction fragments
24 base pair homology arm - 
5’ F1 junctions
                   esama <---  24 bp domain  --->  Vector
Precise junction – CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#4, F1#1       - CTTATGAAAATGTGGTTGTGATCCAAGGGAttGGATCC
F0#4, F1#2       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#5, F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#5, F1#2       - GATAAGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#6, F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#6, F1#2       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#7, F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#7, F1#2       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#9, F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
F0#11,F1#1       - CTTATGAAAATGTGGATGTGATCCAAGGGAttGGATCC
3’F1 junctions
                   Vector<---  24 bp domain  —>  esama
Precise junction - CCATGGAGATGGTGGTGCTGCAGGCGTCATATTCGA
F0#4, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#4, F1#2       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#5, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#5, F1#2       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#6, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#6, F1#2       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#7, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATGAAGGTGCTGCAGGCTTCATATTCGA
F0#7, F1#2       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#9, F1#1       - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
F0#11, F1#1      - CCATGGAGATGGTGGTGCTGCAGGCTTCATATTCGA
flna F1 junction fragments
48 base pair homology arm -
5’ F1 junctions
                    flna <---              48 bp domain              --->Vector
Precise junction – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
F1#1             – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
F1#2             – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
F1#3             – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
F1#4             – ATGACTTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTGGGATCC
3’ F1 junctions
not determined 
msna F1 junctions for exon 2 integration
48 base pair homology arm -
5’ F1 junctions
                    msna <---              48 bp domain              --->  Vector
Precise junction – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#1             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#2             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#3             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#4             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#5             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#6             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#7             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#8             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#9             – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#10            – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#11            – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
F1#12            – GTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATccGGAGCC
3’ F1 junction
                   Vector<---              48 bp domain              ---> msna
Precise junction – AGGAAGCAGCACCACAGGGAAACAGTTATTTGACCAGGTTTGTGTGTGGCCTCTTTTTTT
F1               – AGGAAGCAGCACCACAGGGAAACAGTTATTTGACCAGGTTTGTGTGTGGCCTCTTTTTTT
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aqp1a1 F1 junction fragments
5’ F1 junction
                   aqpa1a<---              48 bp domain              --->  Vector
Precise junction – CCGTCAGTCAGTCAGTCATGAACGAGCTGAAGAGCAAGGCTTTCTGGCGGGCCGccGGATCC
F2 line 1        – CCGTCAGTCAGTCAGTCATGAACGAGCTGAAGAGCAAGGCTTTCTGGCGGGCCGccGGATCC
3’ F1 junction
                   Vector<---              48 bp domain              --->aqpa1a
Precise junction – AGGAAGTCCTGGCCGAGCTGCTGGGAATGACCCTGTTCATCTTCCTCAGCATTACAGCAG
F2 line 1        – AGGAAGTCCTGGCCGAGCTGCTGGGAATGACCCTGTTCATCTTCCTCAGCATTACAGCAG
aqp8a1 F1 junction fragments
5’ F1 junction 
                   aqp1a1<---              48 bp domain              --->  Vector
Precise junction – GAGTCGTCGGCTCTTTCCTCTTCATGTTTGTGGGCTGCGTGTCCGTCATGGGCAttGGATCC
F1#1             – GAGTCGTCGGCTCTTTCCTCTTCATGTTTGTGGGCTGCGTGTCCGTCATGGGCAttGGATCC
3’ F1 junction
                   Vector<---              48 bp domain              --->aqpa1a
Precise junction – AGGAAGACGTGGGCATCAGCGGGAGCATCCAGCCCGCCCTGGCACACGGACTAGCACTGG
F1#1             – AGGAAGACGTGGGCATCAGCGGGAGCATCCAGCCCGCCCTGGCACACGGACTAGCACTGG
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24 base pair homology arm
                    Tyr  <---  24 bp homology  --->   2a
Precise junction – ACAACGACGGATACTTCATGGTGCCCTTCATTGGATCC
Emb. 1 allele 1  - ACAACGACGGATACTTCATGGTGCCCTTCATTGGATCC 3/4 clones
Emb. 1 allele 2  - ACAACGACGGATACTTCATGGTGCCCTTCATTGGACCC 1/4 clones
Emb. 2 allele 1  - ACAACGACGGATACTTCATGGTGCCCTTCATTGGATCC 3/3 clones
                                                    Total 7/7 clones precise integration
a
b


























s, p-value < .0001
* * *
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rb1 e2-e4 deletion tagging
5’ junction
                   rb1 e2<---             48 bp domain             --->                        Vector
Precise junction – CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC
Embryo 1         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise
Embryo 2         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAGAGGGAAATTAGGAGCATGGacGGATCC 4/5 clones precise
Embryo 3         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise
3’ junction
                   Vector                     <---                48 bp domain            --->rb1 e4
Precise junction - AGGAAGCCTAAGGTCAATAGCGCCGTCACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGATTTGTA
Embryo 1         - AGGAAGCCTAAGGTCAATAGCGCCGTCACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGATTTGTA 1/5 clones precise
Embryo 2         - AGGAAGCCTAAGGTCAATAGCGCCGTCACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGATTTGTA 2/5 clones precise
Embryo 3         - AGGAAGCCTAAGGTCAATAGCGCCGTCACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGATTTGTA 5/5 clones precise
rb1 e2-e25 deletion tagging
5’ junction
                   rb1 e2<---             48 bp domain             --->                        Vector
Precise junction - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC  
Embryo 1         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise 
Embryo 2         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise 
Embryo 3         - CGAGGAGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAAAGAGAAATTAGGAGCATGGacGGATCC 5/5 clones precise 
3’ junction 
                   Vector                       <---                48 bp domain            --->rb1 e25 
Precise junction - AGGAAGCCCTCAAAAGACTCAGATTCGATATGGACGGACAAGATGAAGCAGACGGAAGGTGGGAGTCATGATCAGTTTACTCT 
Embryo 1         - AGGAAGCCCTCAAAAGACTCAGATTCGATATGGACGGACAAGATGAAGCAGACGGAAGGTGGGAGTCATGATCAGTTTACTCT 5/5 clones precise 
Embryo 2         - AGGAAGCCCTCAAAAGACTCAGATTCGATATGGACGGACAAGATGAAGCAGACGGAAGGTGGGAGTCATGATCAGTTTACTCT 4/5 clones precise 
Embryo 3         - AGGAAGCCCTCAAAAGACTCAGATTCGATATGGACGGACAAGATGAAGCAGACGGAAGGTGGGAGTCATGATCAGTTTACTCT 3/5 clones precise 
msna e2-6 deletion tagging
5’ junction
                    msna <----               48 bp domain             --->Vector
Precise junction – GATCAGTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATCC
Embryo 1         - GATCAGTGTTCGTGTGACTACGATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATCC 4/4 clones single SNP
Embryo 2         - GATCAGTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATCC 4/5 clones precise
Embryo 3         - GATCAGTGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACCCGGATCC 3/4 clones precise
3’ junction
                   vector<----              48 bp domain             ---> msna
Precise junction - AGGAAGCAAGGGCATGTTGAGGTACAGACAATGGAATGTGCTCTTGCTATTTTTCTGTTT
Embryo 1         - No junction obtained
Embryo 2         - AGGAAGCAAGGGCATGTTGAGGTACAGACAATGAAATGTGCTCTTGCTATTTTTCTGTTT 1/5 clones single SNP
                   AGGAAGCAAGGGCATGTTGAGGTACAGACAATGGAATGTGCTCTTGCTATTTTTCTGTTT 2/5 clones precise
                   AGGAAGCAAGGGCATGTTGAGGTACAGACAATGGAATGGGCTCTTGCTATTTTTCTGTTT 2/5 clones single SNP
Embryo 3         - AGGAAGCAAGGGCATGTTGAGGTACAGACAATGGAATGTGCTCTTGCTATTTTTCTGTTT 4/5 clones precise
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AAVS1 5’ junction
                     AAVS1 <---              48 bp domain              --->Vector
Predicted junction – GCTCTGGTTCTGGGTACTTTTATCTGTCCCCTCCACCCCACAGTGGGGCCACTACGATCG
Repetition 1       - GCTCTGGTTCTGGGTACTTTTATCTGTCCCCTCCACCCCACAGTGGGGCCACTACGATCG
Repetition 2       - GCTCTGGTTCTGGGTACTTTTATCTGTCCCCTCCACCCCACAGTGGGGCCACTACGATCG
Repetition 3       - GCTCTGGTTCTGGGTACTTTTATCTGTCCCCTCCACCCCACAGTGGGGCCACTACGATCG
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tyr       E4   24/24   64%   3/8   38%  
cx43.4*       E2   24/24   50%   0/1   0%  
cx43.4*     E2   48/48   38%   0/4   0%  
esama   E4   24/24   21%   12/18   67%  
flna   E4   48/42   100%   3/4   75%  
msna     E2   48/48   55%   1/4   25%  
msna   E6   48/48   26%   1/3   33%  
aqp1a1   E1   48/48   4%   2/9   22%  
aqp8a1   E1   48/48   14%   1/1   100%  
anxa2a^   E3   48/48   35%   4/4   100%  
         Total   30/61   49%  
  
F0’s  raised  to  adulthood  were  outcrossed  and  screened  for  germline  transmission  of  properly  
localized  fluorescent  signal.  F0s  transmitting/F0s  outcrossed  x  100  =  Germline  transmission  
percentage.  F0s  were  considered  screened  if  75  F1  embryos  were  examined  for  fluorescence.    
*Other  experiments  showed  cx43.4  alleles  could  be  transmitted  through  the  germline  in  3  out  11  
F0  fish  or  27%  with  a  similar  vector  (data  not  shown).  TALEN  indels  of  cx43.4  result  in  sex  
determination  defects,  suggesting  germline  defects  could  contribute  to  variable  frequencies  for  
germline  transmission  (data  not  shown).    
^Transmission  is  based  on  expression  in  the  vasculature  only.  
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noto   E1 2A-­‐TagRFP-­‐CAAX-­‐SV40
genomic  
sgRNA 12/x Average 22 178 12.4% 0.55%
noto   E1 2A-­‐TagRFP-­‐CAAX-­‐SV40
genomic  
sgRNA 24/x Average 30 131 22.9% 0.74%
noto   E1 2A-­‐TagRFP-­‐CAAX-­‐SV40
genomic  
sgRNA 48/x Average 40 114 35.1% 1.01%
noto   E2 2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/x Average 32 150 21.3% 0.66%
noto   E1 pGTag-­‐2A-­‐eGFP-­‐SV40 UgRNA 24/24 Average 45 185 24.3% 0.90%
noto   E1 pGTag-­‐2A-­‐eGFP-­‐SV40 UgRNA 48/48 Average 44 172 25.6% 0.82%










UgRNA 48/48 Average 31 81 38.3% 4.15%
esama  E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactinUgRNA 48/48 Average 34 162 21.0% 0.59%
msna   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 Average 102 185 55.1% 9.87%
msna   E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 Average 25 96 26.0%
anxa2a   E3 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 Average 12 34 35.3%
flna   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/42 Average 9 9 100.0%
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 Average 1 25 4.0%
aqp8a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 Average 3 21 14.3%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 Average 273 463 59.0% 6.44%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 Average 292 486 60.1% 3.78%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 Average 91 151 60.3% 5.92%
kdrl   E3-­‐E30 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 42/48 Average 8 23 34.8%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/27 Average 76 94 80.9%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 Average 29 92 31.5%
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noto   E1 2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 12/x 1 4 32 12.5%
2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 12/x 2 12 91 13.2%
2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 12/x 3 6 55 10.9%
Average 22 178 12.4% 0.55%
noto   E1 2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 24/x 1 10 47 21.3%
2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 24/x 2 10 41 24.4%
2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 24/x 3 10 43 23.3%
Average 30 131 22.9% 0.74%
noto   E1 2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 48/x 1 10 29 34.5%
2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 48/x 2 15 40 37.5%
2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 48/x 3 15 45 33.3%
Average 40 114 35.1% 1.01%
noto   E2 2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/x 1 13 62 21.0%
2A-­‐TagRFP-­‐CAAX-­‐SV40   UgRNA 24/x 2 10 49 20.4%
2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/x 3 9 39 23.1%
Average 32 150 21.3% 0.66%
noto   E1 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/24 1 18 68 26.5%
pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/24 2 9 38 23.7%
pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/24 3 6 28 21.4%
pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/24 4 12 51 23.5%
Average 45 185 24.3% 0.90%
noto   E1 pGTag-­‐2A-­‐eGFP-­‐SV40 UgRNA 48/48 1 9 33 27.3%
pGTag-­‐2A-­‐eGFP-­‐SV40 UgRNA 48/48 2 17 71 23.9%
pGTag-­‐2A-­‐eGFP-­‐SV40 UgRNA 48/48 3 18 68 26.5%
Average 44 172 25.6% 0.82%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 24/24 1 21 31 67.7%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 24/24 2 21 33 63.6%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 24/24 3 42 68 61.8%
Average 84 132 63.6% 1.44%
2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 24/x 1 0 41 0.0%
2A-­‐TagRFP-­‐CAAX-­‐SV40 genomic  sgRNA 24/x 2 0 22 0.0%
Average 0 63 0.0% 0.00%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/24 1 8 21 38.1%
pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/24 2 15 29 51.7%
pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 24/24 3 19 34 55.9%
Average 42 84 50.0% 4.39%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 48/48 1 10 34 29.4%
pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 48/48 2 15 32 46.9%
pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 UgRNA 48/48 3 6 15 40.0%
Average 31 81 38.3% 4.15%
esama  E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 24/24 1 9 40 22.5%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 24/24 2 13 65 20.0%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 24/24 3 12 57 21.1%
Average 34 162 21.0% 0.59%
msna   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 1 11 34 32.4%
48/48 2 91 151 60.3%
Average 102 185 55.1% 9.87%
msna   E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 1 25 96 26.0%
Average 25 96 26.0%
anxa2a   E3 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 1 12 34 35.3%
Average 12 34 35.3%
flna   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/42 1 9 9 100.0%
Average 9 9 100.0%
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 1 1 25 4.0%
2 n/a n/a n/a
Average 1 25 4.0%
aqp8a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 1 3 21 14.3%
Average 3 21 14.3%
rb1   E2-­‐4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 1 48 108 44.0%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 2 56 111 50.0%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 3 53 96 55.0%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 4 116 148 78.0%
Average 273 463 59.0% 6.44%
rb1   E2-­‐25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 1 47 76 62.0%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 2 58 119 49.0%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 3 87 149 58.0%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 4 100 142 70.0%
Average 292 486 60.1% 3.78%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 1 8 13 61.5%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 2 29 34 85.3%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 3 17 34 50.0%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 4 26 48 54.2%
pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 5 11 22 50.0%
Average 91 151 60.3% 5.92%
kdrl   E3-­‐E30 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 42/48 1 8 23 34.8%
Average 8 23 34.8%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/27 1 76 94 80.9%
Average 76 94 80.9%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin UgRNA 48/48 1 29 92 31.5%
Average 29 92 31.5%
.CC-BY-NC 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/431627doi: bioRxiv preprint first posted online Oct. 3, 2018; 
Supplementary  table  3  -­‐  
Germline  Transmission  




noto   E1  24/24 5 3 60.0%
tyr   E4  48/48 8 3 37.5%
cx43.4   24/24 1 0 0.0%
cx43.3   48/48 4 0 0.0%
esama   E2  48/48 18 12 66.7%
msna   E2  48/48 4 1 25.0%
msna   E6  48/48 3 1 33.3%
anxa2a   E3  48/48 4 4 100.0%
flna   E4  48/42 3 3 100.0%
aqp1a1   E1  48/48 9 2 22.2%
aqp8a1   E1  48/48 1 1 100.0%
rb1   E2-­‐E4  48/48 10 0 0.0%
rb1   E2-­‐E25  48/48 16 1 6.3%
msna   E2-­‐E6  48/48 8 0 0.0%
kdrl   E3-­‐E30  44/48 3 0 0.0%
s1pr1   E2-­‐E2  48/48 24 0 0.0%
vegfaa  E3-­‐E7  48/48 16 0 0.0%
mmp14a   E1-­‐E10  48/48 4 0 0.0%
.CC-BY-NC 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/431627doi: bioRxiv preprint first posted online Oct. 3, 2018; 
Supplementary  Table  4  
-­‐  F0  outcrosses  for  
transmission;  asterisk  
denotes  in-­‐cross  









noto   E1 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 24/24 1 Casper 4 28 14.3%
noto   E1 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 24/24 2 Casper 0 172 0.0%
noto   E1 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 24/24 3 Casper 0 15 0.0%
noto   E1 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 24/24 4 Casper 69 146 47.3%
noto   E1 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 24/24 1 Casper 11 61 18.0%
noto   E1 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 24/24 2 Casper 0 81 0.0%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 1 UAS:RFP 0 174 0.0%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 2 UAS:RFP 0 122 0.0%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 3 UAS:RFP 0 45 0.0%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 4 UAS:RFP 0 87 0.0%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 5 UAS:RFP 0 103 0.0%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 6 UAS:RFP 8 89 9.0%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 7 UAS:RFP 13 151 8.6%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 8 UAS:RFP 0 113 0.0%
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 9 UAS:RFP 19 155 12.3%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐ 24/24 1 fli1:EGFP 0 39 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV42 24/24 2 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV43 24/24 3 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV44 24/24 4 fli1:EGFP 0 15 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV45 24/24 5 fli1:EGFP 0 26 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV46 24/24 6 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV47 24/24 7 fli1:EGFP 0 23 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV48 24/24 8 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV49 24/24 9 fli1:EGFP 0 45 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV50 24/24 10 fli1:EGFP 0 82 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 1 fli1:EGFP 0 130 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 2 fli1:EGFP 0 100 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 3 fli1:EGFP 0 75 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 4 fli1:EGFP 0 52 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 5 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 6 fli1:EGFP 0 12 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 7 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 8 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 9 fli1:EGFP 0 34 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 10 fli1:EGFP 0 86 0.0%
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 11 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 12 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 13 fli1:EGFP 0 0 N/A
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 48/48 14 fli1:EGFP 0 0 N/A
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 1 pDB790 0 21 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 2 pDB790 0 212 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 3 pDB790 0 31 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 4 pDB790 1 4 25.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 5 pDB790 1 12 8.3%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 6 pDB790 14 104 13.5%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 7 pDB790 0 87 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 8 pDB790 0 209 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 9 pDB790 0 132 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 10 pDB790 4 18 22.2%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 11 pDB790 0 37 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 12 pDB790 11 43 25.6%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 13 pDB790 14 97 14.4%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 14 pDB790 0 91 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 15 pDB790 7 127 5.5%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 16 pDB790 0 25 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 17 pDB790 30 137 21.9%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 18 pDB790 8 265 3.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 19 pDB790 31 227 13.7%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 20 pDB790 11 146 7.5%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 21 pDB790 0 188 0.0%
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 24/24 22 pDB790 3 66 4.5%
msna   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1 pDB790 42 144 29.2%
msna   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 2 pDB790 0 377 0.0%
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msna   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 3 pDB790 0 202 0.0%
msna   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 4 pDB790 0 150 0.0%
msna   E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1 pDB790 23 311 7.4%
msna   E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 2 pDB790 0 67 0.0%
msna   E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 3 pDB790 0 54 0.0%
anxa2a   E3 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1 pDB790 16 73 21.9%
anxa2a   E3 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 2 pDB790 10 22 45.5%
anxa2a   E3 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 3 pDB790 37 70 52.9%
anxa2a   E3 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 4 pDB790 23 36 63.9%
flna   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/42 1 pDB790 21 64 32.8%
flna   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/42 2 pDB790 1 52 1.9%
flna   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/42 3 pDB790 4 21 19.0%
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1 pDB790 0 N/A N/A
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 2 pDB790 19 281 6.8%
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 3 pDB790 0 N/A N/A
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 4 pDB790 n>1 N/A N/A
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 5 pDB790 0 N/A N/A
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 6 pDB790 0 N/A N/A
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 7 pDB790 0 N/A N/A
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 8 pDB790 0 N/A N/A
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 9 pDB790 0 N/A N/A
aqp8a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1 pDB790 1 7 14.3%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1 pDB790 0 38 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 2 pDB790 0 103 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 3 pDB790 0 61 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 4 pDB790 0 73 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 5 pDB790 0 57 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 6 pDB790 0 69 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 7 pDB790 0 37 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 8 pDB790 0 113 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 9 pDB790 0 79 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 10 pDB790 0 20 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 11 pDB790 0 136 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 12 pDB790 0 124 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 13 pDB790 0 129 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 14 pDB790 0 39 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 15 pDB790 0 123 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 16 pDB790 0 40 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 17 pDB790 0 99 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 18 pDB790 0 208 0.0%
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 19 pDB790 0 241 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1 pDB790 0 49 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 2 pDB790 0 78 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 3 pDB790 0 162 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 4 pDB790 12 25 48.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 5 pDB790 0 79 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 6 pDB790 0 4 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 7 pDB790 0 200 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 8 pDB790 0 38 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 9 pDB790 0 128 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 10 pDB790 0 7 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 11 pDB790 0 119 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 12 pDB790 0 136 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 13 pDB790 0 76 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 14 pDB790 0 159 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 15 pDB790 0 168 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 16 pDB790 0 139 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 17 pDB790 0 25 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 18 pDB790 0 4 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 19 pDB790 0 81 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 20 pDB790 0 71 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 21 pDB790 0 75 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 22 pDB790 0 81 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 23 pDB790 0 76 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 24 pDB790 0 72 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 25 pDB790 0 69 0.0%
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rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 26 pDB790 0 33 0.0%
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 27 pDB790 0 74 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1 pDB790 0 180 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 2 pDB790 0 53 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 3 pDB790 0 0 N/A
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 4 pDB790 0 0 N/A
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 5 pDB790 0 93 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 6 pDB790 0 23 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 7 pDB790 0 357 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 8 pDB790 0 100 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 9 pDB790 0 235 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 10 pDB790 0 237 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 11 pDB790 0 84 0.0%
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 12 pDB790 0 117 0.0%
kdrl   E3-­‐E30 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 42/48 1 pDB790 0 250 0.0%
kdrl   E3-­‐E30 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 42/48 2 pDB790 0 250 0.0%
kdrl   E3-­‐E30 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 42/48 3 pDB790 0 250 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 1
s1pr1   E2-­‐E2  
Animal  2 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 2
s1pr1   E2-­‐E2  
Animal  1 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 3
s1pr1   E2-­‐E2  
Animal  4   0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 4
s1pr1   E2-­‐E2  
Animal  3 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 5
s1pr1   E2-­‐E2  
Animal  6 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 6
s1pr1   E2-­‐E2  
Animal  5 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 7
s1pr1   E2-­‐E2  
Animal  8 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 8
s1pr1   E2-­‐E2  
Animal  7 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 9
s1pr1   E2-­‐E2  
Animal  10 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 10
s1pr1   E2-­‐E2  
Animal  9 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 11
s1pr1   E2-­‐E2  
Animal  12 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 12
s1pr1   E2-­‐E2  
Animal  11 0 150 0.0%
s1pr1   E2-­‐E2   pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 13
s1pr1   E2-­‐E2  
Animal  14 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 14
s1pr1   E2-­‐E2  
Animal  13 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 15
s1pr1   E2-­‐E2  
Animal  16 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 16
s1pr1   E2-­‐E2  
Animal  15 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 17
s1pr1   E2-­‐E2  
Animal  18 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 18
s1pr1   E2-­‐E2  
Animal  17   0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 19
s1pr1   E2-­‐E2  
Animal  20 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 20
s1pr1   E2-­‐E2  
Animal  19 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 21
s1pr1   E2-­‐E2  
Animal  22 0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 22
s1pr1   E2-­‐E2  
Animal  21   0 150 0.0%
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 23
s1pr1   E2-­‐E2  
Animal  24 0 150 0.0%
s1pr1  E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/27 24
s1pr1   E2-­‐E2  
Animal  23 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1
vegfaa   E3-­‐E7  
Animal  2 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 2
vegfaa   E3-­‐E7  
Animal  1 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 3
vegfaa   E3-­‐E7  
Animal  4 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 4
vegfaa   E3-­‐E7  
Animal  3 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 5
vegfaa   E3-­‐E7  
Animal  6 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 6
vegfaa   E3-­‐E7  
Animal  5 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 7
vegfaa   E3-­‐E7  
Animal  8 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 8
vegfaa   E3-­‐E7  
Animal  7 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 9
vegfaa   E3-­‐E7  
Animal  10 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 10
vegfaa   E3-­‐E7  
Animal  9 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 11
vegfaa   E3-­‐E7  
Animal  12 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 12
vegfaa   E3-­‐E7  
Animal  11 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 13
vegfaa   E3-­‐E7  
Animal  14 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 14
vegfaa   E3-­‐E7  
Animal  13 0 150 0.0%
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 15
vegfaa   E3-­‐E7  
Animal  16 0 150 0.0%
vegfaa  E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 16
vegfaa   E3-­‐E7  
Animal  15 0 150 0.0%
mmp14a   E1-­‐E10 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 1
mmp14a   E1-­‐E10  
Animal  2 0 112 0.0%
mmp14a   E1-­‐E10 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 2
mmp14a   E1-­‐E10  
Animal  1 0 112 0.0%
mmp14a   E1-­‐E10 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 3
mmp14a   E1-­‐E10  
Animal  4 0 150 0.0%
mmp14a   E1-­‐E10 pGTag-­‐2A-­‐Gal4VP16-­‐bactin 48/48 4
mmp14a   E1-­‐E10  
Animal  3 0 150 0.0%
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noto   E1 2A-­‐TagRFP-­‐CAAX-­‐SV40 GGGAGCGCAGAGCTGGAGACAGG GGGAGCGCAGAGCTGGAGACAGG aaa CAAACGCCTGTC N/A N/A
noto   E1 2A-­‐TagRFP-­‐CAAX-­‐SV40 GGGAGCGCAGAGCTGGAGACAGG GGGAGCGCAGAGCTGGAGACAGG aaa AGCATAACCAACCAAACGCCTGTC N/A N/A
noto   E1 2A-­‐TagRFP-­‐CAAX-­‐SV40 GGGAGCGCAGAGCTGGAGACAGG GGGAGCGCAGAGCTGGAGACAGG aaa AGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTC N/A N/A
noto   E2 2A-­‐TagRFP-­‐CAAX-­‐SV40 GACTGGAGAAAGAGTTCGCGCGG GACTGGAGAAAGAGTTCGCGCGG aaa CTGTCCAGACTGGAGAAAGAGTTC N/A N/A
noto   E2 2A-­‐TagRFP-­‐CAAX-­‐SV40 GACTGGAGAAAGAGTTCGCGCGG GGGAGGCGTTCGGGCCACAGCGG N/A CTGTCCAGACTGGAGAAAGAGTTC N/A N/A
noto   E1 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 GGGAGCGCAGAGCTGGAGACAGG GGGAGGCGTTCGGGCCACAGCGG aaa AGCATAACCAACCAAACGCCTGTC N/A TCCAGCTCTGCGCTCCCGCTTATT
noto   E1 pGTag-­‐2A-­‐eGFP-­‐SV40 GGGAGCGCAGAGCTGGAGACAGG GGGAGGCGTTCGGGCCACAGCGG aaa AGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTC ggg TCCAGCTCTGCGCTCCCGCTTATTTACTCGCAGATGCCACACTTCGCG
tyr   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin GTTCCTGTAGAGAGGGATGAAGG GGGAGGCGTTCGGGCCACAGCGG aaa ACGGATACTTCATGGTGCCCTTCA N/A TCCCTCTCTACAGGAACGGAGACT
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 GAGCCATATCTTGCCCACGAAGG GGGAGGCGTTCGGGCCACAGCGG ccc AAATCTCCAACCACTCCACCTTCG ggg TGGGCAAGATATGGCTCACGTTAT
cx43.4   E2 pGTag-­‐2A-­‐TagRFP-­‐CAAX-­‐SV40 GAGCCATATCTTGCCCACGAAGG GGGAGGCGTTCGGGCCACAGCGG ccc GTTTTCTTACGCGGTTGTTGGATGAAATCTCCAACCACTCCACCTTCG aaa TGGGCAAGATATGGCTCACGTTATTCATCATCTTCCGCATTGTTTTGA
esama   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin GGATGTGATCCAAGGGAAGATGG GGGAGGCGTTCGGGCCACAGCGG ctc AAAATGTGGATGTGATCCAAGGGA gag GATCCAATCCCTTGGATCACATCCACATTTT
msna   E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin GTTTCCCTGTGGTGCTGGGTTGG GGGAGGCGTTCGGGCCACAGCGG ttt TGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACC GCG cagcaccacagggaaacagttatttgaccaggtttgtgtgtggcctct
msna   E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin GTCTGGCACGAGGAGCACAAGGG GGGAGGCGTTCGGGCCACAGCGG aaa GAATAAGGAGCAATGGGAGGAAAGAATTCAGGTCTGGCACGAGGAGCA aaa CAAGGGCATGTTGAGGTACAGACAATGGAATGTGCTCTTGCTATTTTT
anxa2a   E3 pGTag-­‐2A-­‐Gal4VP16-­‐bactin TCTGGATCAAAGTTGGCCTCTGG GGGAGGCGTTCGGGCCACAGCGG GGG CTCGAACTGGGCGGAGGAGAGCCCACCTACCCTACTGTTGTTCCAGAG GGG GCCAACTTTGATCCAGACAAAGATGCTGCCAGGATTGAGACCGCTATC
flna   E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin GGATTGAGTTTGGGCCTCAGAGG GGGAGGCGTTCGGGCCACAGCGG GGG TACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTG CCC AGGCCCAAACTCAATCCCAAAAAGGCCCGTGCTTATGGACCA
aqp1a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin GGCTTTCTGGCGGGCCGTCCTGG GGGAGGCGTTCGGGCCACAGCGG GGG GTCAGTCAGTCATGAACGAGCTGAAGAGCAAGGCTTTCTGGCGGGCCG TTT TCCTGGCCGAGCTGCTGGGAATGACCCTGTTCATCTTCCTCAGCATTA
aqp8a1   E1 pGTag-­‐2A-­‐Gal4VP16-­‐bactin CGTGTCCGTCATGGGCAACGTGG GGGAGGCGTTCGGGCCACAGCGG AAA TCGGCTCTTTCCTCTTCATGTTTGTGGGCTGCGTGTCCGTCATGGGCA TTT ACGTGGGCATCAGCGGGAGCATCCAGCCCGCCCTGGCACACGGACTAG
rb1   E2-­‐E4 pGTag-­‐2A-­‐Gal4VP16-­‐bactin E2  GGAGAGGGAGATCAGATCGATGG,  E4  GTCACAGCAGAGTTCACTTTAGG GGGAGGCGTTCGGGCCACAGCGG N/A GCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGA N/A ACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGA
rb1   E2-­‐E25 pGTag-­‐2A-­‐Gal4VP16-­‐bactin E2  GGAGAGGGAGATCAGATCGATGG,  E25  GTCAAAGCGCAGCCTCTTCAGGG GGGAGGCGTTCGGGCCACAGCGG N/A GCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGA N/A ATGGACGGACAAGATGAAGCAGACGGAAGgtgggagtcatgatcagtt
msna   E2-­‐E6 pGTag-­‐2A-­‐Gal4VP16-­‐bactin E2  GTTTCCCTGTGGTGCTGGGTTGG,  E6  GTCTGGCACGAGGAGCACAAGGG GGGAGGCGTTCGGGCCACAGCGG ttt TGTTCGTGTGACTACAATGGATGCCGAGCTGGAGTTTGCCATCCAACC aaa CAAGGGCATGTTGAGGTACAGACAATGGAATGTGCTCTTGCTATTTTT
kdrl   E3-­‐E30 pGTag-­‐2A-­‐Gal4VP16-­‐bactin E3  GGCTAGCAGAAATGTGTCATCGG,  E30  GGAGGACTCGTCCCTTGACTCGG GGGAGGCGTTCGGGCCACAGCGG CCC GATCAACTGCACTGCACTGGAGGCTGGCTAGCAGAAATGTGT N/A actcggagatggagtgtcacagtcctcctccagactataactatgtgg
s1pr1   E2-­‐E2 pGTag-­‐2A-­‐Gal4VP16-­‐bactin E2  GGAGAACCAGAACATTTTCCAGG,  E2  GGGAAACCATAGTGTCTTCTTGG GGGAGGCGTTCGGGCCACAGCGG TTT AGCGGACTCTGTTGTGTTCATCATCGTGTGCTGCTTCATCATCCTGGA GGG TTCTGGGAATATCACCTCTTCTTCTTAAAGGGACTATTCGTGAACTTT
vegfaa   E3-­‐E7 pGTag-­‐2A-­‐Gal4VP16-­‐bactin E3  GTGCAAGACCCGAGAGCTGCTGG,  E7  CGTTCGCTCGATCATCATCTTGG GGGAGGCGTTCGGGCCACAGCGG CCC TTCCCTTCATGGATGTGTATAAAAAGAGTGCGTGCAAGACCCGAGAGC CCC TGATGATCGAGCGAACGCCGGGCAGAACTCTGCATGAAGGAAGGAACT
mmp14a   E1-­‐E10 pGTag-­‐2A-­‐Gal4VP16-­‐bactin E1  GCACCAGAAACACACTTGCGAGG,  E10  GGGAGCCGGCACAGATGAGGAGG GGGAGGCGTTCGGGCCACAGCGG CCC GTTACCGAAACTGCAGACGTTACCTCGGCTTCTGCCTCTCGCCCTCGC CCC AGGAGGTGCTCATTATTGAAGTGGACGGCTCGGAGGGCGGAGCCATGG
ROSA26 HMEJ  donor TTAACCTGATTCTTGGGCGTTGTCCTGCAGGGGATTGAGCAGGTGTACGA GGGAGGCGTTCGGGCCACAGCGG TGAT TGGGCGGGATTCTTTTGCCCTGGCTTAACCTGATTCTTGGGCGTTGTC GCT TGCAGGGGATTGAGCAGGTGTACGAGGACGAGCCCAATTTCTCTATAT

































AAVS1 HMEJ  donor GTCACCAATCCTGTCCCTAGTGG GGGAGGCGTTCGGGCCACAGCGG ccc GTTCTGGGTACTTTTATCTGTCCCCTCCACCCCACAGTGGGGCCACTA aaa GGGACAGGATTGGTGACAGAAAAGCCCCATCCTTAGGCCTCCTCCTTC
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Primer  name Sequence Purpose
notojxn5'f GCTTTTTGGACTAAACAGACGCCATG Junction  fragment  analysis
notojxn3'r cttgtgcgtacacagctccacg Junction  fragment  analysis
notojxn3'delr CGATGTTATACTTGCTTCTTTTTAGTTTTGTACATAT Junction  fragment  analysis
tyrjxn5'f CATCTTTGAGCAGTGGTTGAGGAGA Junction  fragment  analysis
tyrjxn3'r CACCTGGATCCTGTAAATATGCATATTCATATC Junction  fragment  analysis
esamajxn5'f ggtctttcagtcagcgagtttaatgtc Junction  fragment  analysis
esamajxn3'r CATTTCAGTGCTGGTAGCAGACTG Junction  fragment  analysis
cx43.4jxn5'f GCAGGACTGAGACGGTGGTA Junction  fragment  analysis
cx43.4fxn3'r CAAATGCATCGTAGCAAACG Junction  fragment  analysis
Rb2jF AAGGACAAGGATCCTGAGTTTG Junction  fragment  analysis
galjf GCAAACGGCCTTAACTTTCC Junction  fragment  analysis
GaljR GCCTTGATTCCACTTCTGTCA Junction  fragment  analysis
Rb4jR GCTTTGCATCACAACCTCAA Junction  fragment  analysis
Rb25jR AGCCAGCTTCTGGATCAGTG Junction  fragment  analysis
RFP5'jxnr CCTTAATCAGTTCCTCGCCCTTAGA Junction  fragment  analysis
sv403'jxnf GGGGAGGTGTGGGAGGTTTT Junction  fragment  analysis
gfp5'R GCTGAACTTGTGGCCGTTTA Junction  fragment  analysis
GFP3'F ACATGGTCCTGCTGGAGTTC Junction  fragment  analysis
F-­‐msna-­‐exon2 TTCCTTCATTCATTCATTGACA Junction  fragment  analysis
R-­‐msna-­‐exon2 GGGCACGGCTACAAAGAAG Junction  fragment  analysis
R-­‐msna-­‐exon6 CGTGTGATTGACAGGGTCAC Junction  fragment  analysis
F-­‐msna-­‐exon6 GTTCTGGAGCAGCACAAGC Junction  fragment  analysis
anxa2a5'Cut3'JxnPrR CTTCCAGACAGGACGAGTGA Junction  fragment  analysis
anxa2a5'Cut5'JxnPrF TTTCCTCATTGTTTGGCTGT Junction  fragment  analysis
F-­‐1a1junc agattagaggcgtcagtccg Junction  fragment  analysis
R-­‐1a1junc gctgaggaagatgaacaggg Junction  fragment  analysis
KDRLEx3JxnF TTGTTTTTGTTGTGACTTCCAAT Junction  fragment  analysis
KDRLEx30JxnR GGGTGGTGTGGAGTAACGAA Junction  fragment  analysis
S1PR1.5'JxnF ACAAGGACCCGGGACTCA Junction  fragment  analysis
S1PR1.3'JxnR CGAGACGAAAAAGTTCACGA Junction  fragment  analysis
vegfaaEx3.5'JxnF AACACTCTCGCTTTGCTTCC Junction  fragment  analysis
vegfaaEx7.3'JxnR TGCTGTGCCGTTTAAAAAGTT Junction  fragment  analysis
R-­‐8a1-­‐exon1_junc tgatttccccaaaaattgct Junction  fragment  analysis
F-­‐8a1-­‐exon1_junc gcccttcttcgagcactaca Junction  fragment  analysis
F-­‐mmp14a-­‐junc ? Junction  fragment  analysis
R-­‐mmp14a-­‐junc ? Junction  fragment  analysis
notoSBf CAGATGCCACACTTCGCGT Southern  blot  analysis
notoSBr CGATGTTATACTTGCTTCTTTTTAGTTTTGTACATAT Southern  blot  analysis
tyrSBe3f GTTTTGCTAATCCTGAGACGGGTTTG Southern  blot  analysis
tyrSBe3r CTGTCAATAAAAGCATGATGTATGATGAAAATGG Southern  blot  analysis
esamaSBe3f ATCATCTCATTCGTCAATGGAGACTTCAG Southern  blot  analysis
esamaSBi4r CACAGTGTGGCAGTGAGCATTC Southern  blot  analysis
gal4SBr CTGAAGAACAACTGGGAGTGTCGC Southern  blot  analysis
gal4SBf TTACATATCCAGAGCGCCGTAGGG Southern  blot  analysis
rfpSBf ATGGTGTCTAAGGGCGAAGAGC Southern  blot  analysis
rfpSBr AGCTTCAGGGCCATGTCGC Southern  blot  analysis
F-­‐2A-­‐Gal4-­‐BamHI GGATCCGGAGCCACGAACTTCTCTCTGTTAAAGCAAGCAGGAGACGTGGAAGAAAACCCCGGTCCTtctagaAAGCTACTGTCTTCTATCGAACAAGCAp Tag  vector  cloning
R-­‐Gal4-­‐NcoI gcatCCATGGTAATTTATTTAGCAGTAGATAGCTATATTGTGTGAAACGC pGTag  vector  cloning
F-­‐eGFP-­‐speI agacatactagtatggtgagcaagggcgaggagctg pGTag  vector  cloning
R-­‐eGFP-­‐XhoI tggatcCtcgagttacttgtacagctcgt pGTag  vector  cloning
F-­‐p494-­‐XhoI cgctgcctcgagGGCGCGCCTCTAGAACTATAG pGTag  vector  cloning
R-­‐p494-­‐SpeI agccatactagtAGGACCGGGGTTTTCTT pGTag  vector  cloning
F-­‐lacZ tgatacacgcaggtgcgcaacgcaattaatgtgagtt pGTag  vector  cloning
R-­‐lacZ atcctgtggcaggtccattcgccattcaggctgc pGTag  vector  cloning
F-­‐lacZ-­‐universal-­‐1 GGGAGGCGTTCGGGCCACAGCGGacacgcaggtgcgcaacgcaattaatg pGTag  vector  cloning
R-­‐lacZ-­‐universal-­‐BamHIctgatcggatcctgtggcaggtccattcg pGTag  vector  cloning
F-­‐lacZ-­‐universal-­‐EcoRI gtacatgaattcGGGAGGCGTTCGGGCCACAG pGTag  vector  cloning
F-­‐3’-­‐uni-­‐1 CGTTGTCTAGCAAGGAAGTGAaga pGTag  vector  cloning
R-­‐3’-­‐uni-­‐1 GGGAGGCGTTCGGGCCACAGCGGagaagagcatattcaatgtcg pGTag  vector  cloning
F-­‐3’-­‐uniNco1 tgcaGccatggCGTTGTCTAGCAAGGAAGTGAaga pGTag  vector  cloning
R-­‐3’-­‐uniEagI tcgaGcggccgAGATCCCATCGCTAGCGGG pGTag  vector  cloning
F-­‐TagRFPfix 5'phos\cttaatcagttcctcgcccttag pGTag  vector  cloning
R-­‐TagRFPfix 5'phos-­‐gagaacatgcacatgaagctgtac pGTag  vector  cloning
F-­‐BBfix 5'phos\AATACGCAAACCGCCTCTCC pGTag  vector  cloning
R-­‐BBfix 5'phos\GGGCGCaCaTCCGCTTC pGTag  vector  cloning
F-­‐Bactfix 5'phos\TTTAAAAGTCAAACCACCATGACTG pGTag  vector  cloning
R-­‐Bactfix 5'phos\CTGGCAGTTCCTTCCTGTTAA pGTag  vector  cloning
F-­‐Bact-­‐AscI ATATGTGGCGCGCCACGGACTGTTACCACTTCACG pGTag  vector  cloning
R-­‐Bact-­‐NcoI ACAACGCCATGGTAATTTATTTAGC pGTag  vector  cloning
F-­‐gal4-­‐Ecofix 5'phos\aCAGATCTCTCGAGCCGCCCC pGTag  vector  cloning
R-­‐gal4-­‐Ecofix 5'phos\ATTCCCGGGGTCGACCTCGA pGTag  vector  cloning
noto   E1  guide taatacgactcactataGGGAGCGCAGAGCTGGAGACgttttagagctagaa gRNA  oligo  A
noto   E2  guide taatacgactcactataGACTGGAGAAAGAGTTCGCGgttttagagctagaa gRNA  oligo  A
tyr   E4  guide taatacgactcactatagGTTCCTGTAGAGAGGGATGAgttttagagctagaa gRNA  oligo  A
cx43.4   E2  guide taatacgactcactataGGGCCATATCTTGCCCACGAgttttagagctagaa gRNA  oligo  A
esama   E2  guide taatacgactcactataGGATGTGATCCAAGGGAAGAgttttagagctagaa gRNA  oligo  A
msna   E2  guide taatacgactcactataGGTTCCCTGTGGTGCTGGGTgttttagagctagaa gRNA  oligo  A
msna   E6  guide taatacgactcactataGGCTGGCACGAGGAGCACAAgttttagagctagaa gRNA  oligo  A
anxa2a   E3  guide taatacgactcactataGGTGGATCAAAGTTGGCCTCgttttagagctagaa gRNA  oligo  A
flna   E4  guide taatacgactcactataGGATTGAGTTTGGGCCTCAGgttttagagctagaa gRNA  oligo  A
aqp1a1   E1 taatacgactcactataGGCTTTCTGGCGGGCCGTCCgttttagagctagaa gRNA  oligo  A
aqp8a1   E1 taatacgactcactataGGTGTCCGTCATGGGCAACGgttttagagctagaa gRNA  oligo  A
rb1   E2    guide taatacgactcactataGGAGAGGGAGATCAGATCGAgttttagagctagaa gRNA  oligo  A
rb1   E4  guide taatacgactcactataGGCACAGCAGAGTTCACTTTgttttagagctagaa gRNA  oligo  A
rb1   E25  guide taatacgactcactataGGCAAAGCGCAGCCTCTTCAgttttagagctagaa gRNA  oligo  A
kdrl   E3  guide taatacgactcactataGGCTAGCAGAAATGTGTCATgttttagagctagaa gRNA  oligo  A
kdrl   E30  guide taatacgactcactataGGAGGACTCGTCCCTTGACTgttttagagctagaa gRNA  oligo  A
s1pr1   E2a  guide taatacgactcactataGGAGAACCAGAACATTTTCCgttttagagctagaa gRNA  oligo  A
s1pr1   E2b  guide taatacgactcactataGGGAAACCATAGTGTCTTCTgttttagagctagaa gRNA  oligo  A
vegfaa   E3  guide taatacgactcactataGGGGCAAGACCCGAGAGCTGCgttttagagctagaa gRNA  oligo  A
vegfaa   E7  guide taatacgactcactataGGGTTCGCTCGATCATCATCTgttttagagctagaa gRNA  oligo  A
mmp14a   E1  guide taatacgactcactataGGACCAGAAACACACTTGCGgttttagagctagaa gRNA  oligo  A
mmp14a   E10  guide taatacgactcactataGGGAGCCGGCACAGATGAGGgttttagagctagaa gRNA  oligo  A
CRISPR  Oligo  B AAAAGCACCGACTCGGTGCCACTTTTTCAAGTTGATAACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC Oligo  B  for  gRNA  synthesis
noto   E1  5'  arm  bait  A  
12 aattcGGGAGCGCAGAGCTGGAGACAGGCAAACGTCTGTCg Homology  arm  oligo
noto   E1  5'  arm  bait  B  
12 gatccGACAGACGTTTGCCTGTCTCCAGCTCTGCGCTCCCg Homology  arm  oligo
noto   E1  5'  arm  bait  A  
24 aattcGGGAGCGCAGAGCTGGAGACAGGAGCATAACCAACCAAACGCCTGTCg Homology  arm  oligo
noto   E1  5'  arm  bait  B  
24 gatccGACAGGCGTTTGGTTGGTTATGCTCCTGTCTCCAGCTCTGCGCTCCCg Homology  arm  oligo
noto   E1  5'  arm  bait  A  
48 aattcGGGAGCGCAGAGCTGGAGACAGGAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTg Homology  arm  oligo
noto   E1  5'  arm  bait  B  
48 gatccACAGGCGTTTGGTTGGTTATGCTCCGGTACGCGTTTGTTCGTTCTCTCCTGTCTCCAGCTCTGCGCTCCCg Homology  arm  oligo
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noto   E1  5'  arm  A  24 aattcGGGAGCGCAGAGCTGGAGACAGGaaaAGCATAACCAACCAAACGCCTGTCg Homology  arm  oligo
noto   E1  5'  arm  B  24 gatccGACAGGCGTTTGGTTGGTTATGCTtttCCTGTCTCCAGCTCTGCGCTCCCg Homology  arm  oligo
noto   E1  3'  arm  A  24 catggTCCAGCTCTGCGCTCCCGCTTATTCCGCTGTGGCCCGAACGCCTCCCc Homology  arm  oligo
noto   E1  3'  arm  B  24 ggccgGGGAGGCGTTCGGGCCACAGCGGAATAAGCGGGAGCGCAGAGCTGGAc Homology  arm  oligo
noto   E1  5'  arm  A  48 GCGGaaaAGAGAACGAACAAACGCGTACCGGAGCATAACCAACCAAACGCCTGTC Homology  arm  oligo
noto   E1  5'  arm  B  48 atccGACAGGCGTTTGGTTGGTTATGCTCCGGTACGCGTTTGTTCGTTCTCTttt Homology  arm  oligo
noto   E1  3'  arm  A  48 aagTCCAGCTCTGCGCTCCCGCTTATTTACTCGCAGATGCCACACTTCGCGggg Homology  arm  oligo
noto   E1  3'  arm  B  48 cggcccCGCGAAGTGTGGCATCTGCGAGTAAATAAGCGGGAGCGCAGAGCTGGA Homology  arm  oligo
noto   E2  5'  arm  bait  A  
24   aattcGACTGGAGAAAGAGTTCGCGCGGGCTGTCCAGACTGGAGAAAGAGTTCg Homology  arm  oligo
noto   E2  5'  arm  bait  B  
24 gatccGAACTCTTTCTCCAGTCTGGACAGCCCGCGCGAACTCTTTCTCCAGTCg Homology  arm  oligo
noto   E2  5'  arm  
UgRNA  bait  A  24   aattcGGGAGGCGTTCGGGCCACAGCGGGCTGTCCAGACTGGAGAAAGAGTTCg
noto   E2  5'  arm  
UgRNA  bait  B  24 gatccGAACTCTTTCTCCAGTCTGGACAGCCCGCTGTGGCCCGAACGCCTCCCg
tyr   E4  5'  arm  A  48 aattcGGGAGGCGTTCGGGCCACAGCGGaaaCCAACGCCCCCATCGGACACAACGACGGATACTTCATGGTGCCCTTCAttg Homology  arm  oligo
tyr   E4  5'  arm  B  48 gatccaaTGAAGGGCACCATGAAGTATCCGTCGTTGTGTCCGATGGGGGCGTTGGtttCCGCTGTGGCCCGAACGCCTCCCg Homology  arm  oligo
tyr   E4  3'  arm  A  48 catggTCCCTCTCTACAGGAACGGAGACTATTTTCTCTCCACGAAAGCCCTGGaaaCCGCTGTGGCCCGAACGCCTCCCc Homology  arm  oligo
tyr   E4  3'  arm  B  48 ggccgGGGAGGCGTTCGGGCCACAGCGGtttCCAGGGCTTTCGTGGAGAGAAAATAGTCTCCGTTCCTGTAGAGAGGGAc Homology  arm  oligo
cx43.4   E2  5'  arm  A  24
GCGGcccAAATCTCCAACCACTCCACCTTCGtg Homology  arm  oligo
cx43.4   E2  5'  arm  B  24
ATCCcaCGAAGGTGGAGTGGTTGGAGATTTggg Homology  arm  oligo
cx43.4   E2  3'  arm  A  24
AAGTGGGCAAGATATGGCTCACGTTATggg Homology  arm  oligo
cx43.4   E2  3'  arm  B  24
CGGcccATAACGTGAGCCATATCTTGCCCA Homology  arm  oligo
cx43.4   E2  5'  arm  A  48
GCGGcccGTTTTCTTACGCGGTTGTTGGATGAAATCTCCAACCACTCCACCTTCGtg Homology  arm  oligo
cx43.4   E2  5'  arm  B  48
ATCCcaCGAAGGTGGAGTGGTTGGAGATTTCATCCAACAACCGCGTAAGAAAACggg Homology  arm  oligo
cx43.4   E2  3'  arm  A  48
AAGTGGGCAAGATATGGCTCACGTTATTCATCATCTTCCGCATTGTTTTGAaaa Homology  arm  oligo
cx43.4   E2  3'  arm  B  48
CGGtttTCAAAACAATGCGGAAGATGATGAATAACGTGAGCCATATCTTGCCCA Homology  arm  oligo
esama   E2  5'  arm  A  24
AATTCGGGAGGCGTTCGGGCCACAGCGGCTCAAAATGTGGATGTGATCCAAGGGATTG Homology  arm  oligo
esama   E2  5'  arm  B  24
GATCCAATCCCTTGGATCACATCCACATTTTGAGCCGCTGTGGCCCGAACGCCTCCCG Homology  arm  oligo
esama   E2  3'  arm  A  24
CATGGAGATGGTGGTGCTGCAGGCTTCATAGACCGCTGTGGCCCGAACGCCTCCCC Homology  arm  oligo
esama   E2  3'  arm  B  24
GGCCGGGGAGGCGTTCGGGCCACAGCGGTCTATGAAGCCTGCAGCACCACCATCTC Homology  arm  oligo
msna   E2  5'  arm  A  48 GCGGTTTtgttcgtgtgactacaatggatgccgagctggagtttgccatccaaccC Homology  arm  oligo
msna   E2  5'  arm  B  48 ATCCGggttggatggcaaactccagctcggcatccattgtagtcacacgaacaAAA Homology  arm  oligo
msna   E2  3'  arm  A  48 AAGcagcaccacagggaaacagttatttgaccaggtttgtgtgtggcctctGCG Homology  arm  oligo
msna   E2  3'  arm  B  48 cggCGCagaggccacacacaaacctggtcaaataactgtttccctgtggtgctg Homology  arm  oligo
msna   E6  5'  arm  A  48 GCGGaaaGAATAAGGAGCAATGGGAGGAAAGAATTCAGGTCTGGCACGAGGAGCAc Homology  arm  oligo
msna   E6  5'  arm  B  48 ATCCgTGCTCCTCGTGCCAGACCTGAATTCTTTCCTCCCATTGCTCCTTATTCttt Homology  arm  oligo
msna   E6  3'  arm  A  48 aagCAAGGGCATGTTGAGGTACAGACAATGGAATGTGCTCTTGCTATTTTTaaa Homology  arm  oligo
msna   E6  3'  arm  B  48 cggtttAAAAATAGCAAGAGCACATTCCATTGTCTGTACCTCAACATGCCCTTG Homology  arm  oligo
anxa2a   E3  5'  arm  A GCGGGGGCTCGAACTGGGCGGAGGAGAGCCCACCTACCCTACTGTTGTTCCAGAG Homology  arm  oligo
anxa2a   E3  5'  arm  B ATCCCTCTGGAACAACAGTAGGGTAGGTGGGCTCTCCTCCGCCCAGTTCGAGCCC Homology  arm  oligo
anxa2a   E3  3'  arm  A AAGGCCAACTTTGATCCAGACAAAGATGCTGCCAGGATTGAGACCGCTATCGGG Homology  arm  oligo
anxa2a   E3  3'  arm  B CGGCCCGATAGCGGTCTCAATCCTGGCAGCATCTTTGTCTGGATCAAAGTTGGC Homology  arm  oligo
flna   E4  5'  arm  A GCGGGGGTACCTGTCCCAGTTTCCCAAAGCCAAACTCAAGCCTGGTGCCCCTCTG Homology  arm  oligo
flna   E4  5'  arm  B ATCCCAGAGGGGCACCAGGCTTGAGTTTGGCTTTGGGAAACTGGGACAGGTACCC Homology  arm  oligo
flna   E4  3'  arm  A AAGAGGCCCAAACTCAATCCCAAAAAGGCCCGTGCTTATGGACCACCC Homology  arm  oligo
flna   E4  3'  arm  B CGGGGGTGGTCCATAAGCACGGGCCTTTTTGGGATTGAGTTTGGGCCT Homology  arm  oligo
aqp1a1   E1  5'  arm  A GCGGGGGGTCAGTCAGTCATGAACGAGCTGAAGAGCAAGGCTTTCTGGCGGGCCGCC Homology  arm  oligo
aqp1a1   E1  5'  arm  B ATCCGGCGGCCCGCCAGAAAGCCTTGCTCTTCAGCTCGTTCATGACTGACTGACCCC Homology  arm  oligo
aqp1a1   E1  3'  arm  A AAGTCCTGGCCGAGCTGCTGGGAATGACCCTGTTCATCTTCCTCAGCATTATTT Homology  arm  oligo
aqp1a1   E1  3'  arm  B CGGAAATAATGCTGAGGAAGATGAACAGGGTCATTCCCAGCAGCTCGGCCAGGA Homology  arm  oligo
aqp8a1   E1  5'  arm  A GCGGAAATCGGCTCTTTCCTCTTCATGTTTGTGGGCTGCGTGTCCGTCATGGGCATT Homology  arm  oligo
aqp8a1   E1  5'  arm  B ATCCAATGCCCATGACGGACACGCAGCCCACAAACATGAAGAGGAAAGAGCCGATTT Homology  arm  oligo
aqp8a1   E1  3'  arm  A AAGACGTGGGCATCAGCGGGAGCATCCAGCCCGCCCTGGCACACGGACTAGTTT Homology  arm  oligo
aqp8a1   E1  3'  arm  B CGGAAACTAGTCCGTGTGCCAGGGCGGGCTGGATGCTCCCGCTGATGCCCACGT Homology  arm  oligo
rb1   E2    5'  arm  A gcggGCTCCAGTCCACTAACTCCATCTGTGATCATGCATGGAGAATATGGGAaAGaGAaATtAGgagcATGGac Homology  arm  oligo
rb1   E2    5'  arm  B atccgtCCATgctcCTaATtTCtCTtTCCCATATTCTCCATGCATGATCACAGATGGAGTTAGTGGACTGGAGC Homology  arm  oligo
rb1   E2    3'  arm  A -­‐ Homology  arm  oligo
rb1   E2    3'  arm  B -­‐ Homology  arm  oligo
rb1   E4    5'  arm  A -­‐ Homology  arm  oligo
rb1   E  4  5'  arm  B -­‐ Homology  arm  oligo
rb1   E4    3'  arm  A aagCCTAAgGTcAAtagcGCcGTcACCCGCCTAGAGAACAAATACGATGTGACTTTGGCCCTCTACCAAAGA Homology  arm  oligo
rb1   E4    3'  arm  B cggTCTTTGGTAGAGGGCCAAAGTCACATCGTATTTGTTCTCTAGGCGGGTgACgGCgctaTTgACcTTAGG Homology  arm  oligo
rb1   E25    5'  arm  A -­‐ Homology  arm  oligo
rb1   E25    5'  arm  B -­‐ Homology  arm  oligo
rb1   E25    3'  arm  A aagCCCTcAAaAGaCTcagaTTcGAtATGGACGGACAAGATGAAGCAGACGGAAGgtgggagtcatgatcagtt Homology  arm  oligo
rb1   E25    3'  arm  B cggaactgatcatgactcccacCTTCCGTCTGCTTCATCTTGTCCGTCCATaTCgAAtctgAGtCTtTTgAGGG Homology  arm  oligo
kdrl   E3  5'  arm  A GCGGCCCGATCAACTGCACTGCACTGGAGGCTGGCTAGCAGAAATGTGTCC Homology  arm  oligo
kdrl   E3  5'  arm  B ATCCGGACACATTTCTGCTAGCCAGCCTCCAGTGCAGTGCAGTTGATCGGG Homology  arm  oligo
kdrl   E30  3'  arm  A AAGACTCGGAGATGGAGTGTCACAGTCCTCCTCCAGACTATAACTATGTGGCCC Homology  arm  oligo
kdrl   E30  3'  arm  B CGGGGGCCACATAGTTATAGTCTGGAGGAGGACTGTGACACTCCATCTCCGAGT Homology  arm  oligo
s1pr1   E2  5'  arm  A GCGGtttAGCGGACTCTGTTGTGTTCATCATCGTGTGCTGCTTCATCATCCTGGAa Homology  arm  oligo
s1pr1   E2  5'  arm  B ATCCtTCCAGGATGATGAAGCAGCACACGATGATGAACACAACAGAGTCCGCTaaa Homology  arm  oligo
s1pr1   E2  3'  arm  A AAGTTCTGGGAATATCACCTCTTCTTCTTAccc Homology  arm  oligo
s1pr1   E2  3'  arm  B CGGgggTAAGAAGAAGAGGTGATATTCCCAGAA Homology  arm  oligo
vegfaa   E3  5'  arm  A GCGGCCCTTCCCTTCATGGATGTGTATAAAAAGAGTGCGTGCAAGACCCGAGAGCAA Homology  arm  oligo
vegfaa   E3  5'  arm  B ATCCTTGCTCTCGGGTCTTGCACGCACTCTTTTTATACACATCCATGAAGGGAAGGG Homology  arm  oligo
vegfaa   E7  3'  arm  A AAGTGATGATCGAGCGAACGCCGGGCAGAACTCTGCATGAAGGAAGGAACTCCC Homology  arm  oligo
vegfaa   E7  3'  arm  B CGGGGGAGTTCCTTCCTTCATGCAGAGTTCTGCCCGGCGTTCGCTCGATCATCA Homology  arm  oligo
mmp14a   E1  5'  arm  A GCGGCCCGTTACCGAAACTGCAGACGTTACCTCGGCTTCTGCCTCTCGCCCTCGCC Homology  arm  oligo
mmp14a   E1  5'  arm  B ATCCGGCGAGGGCGAGAGGCAGAAGCCGAGGTAACGTCTGCAGTTTCGGTAACGGG Homology  arm  oligo
mmp14a   E10  3'  arm  A AAGAGGAGGTGCTCATTATTGAAGTGGACGGCTCGGAGGGCGGAGCCATGGCCC Homology  arm  oligo
mmp14a   E10  3'  arm  B CGGGGGCCATGGCTCCGCCCTCCGAGCCGTCCACTTCAATAATGAGCACCTCCT Homology  arm  oligo
anxa2a 5'Cut3'JxnPrR CTTCCAGACAGGACGAGTGA Junction  fragment  analysis
anxa2a 5'Cut5'JxnPrF TTTCCTCATTGTTTGGCTGT Junction  fragment  analysis
flnaEx4  PrF GTGGACGAGCACTCCGTTAT Junction  fragment  analysis
flnaEx4.3'JxnR AACCGCAAACAAAGCTGTTC
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Gene  Targeting  Protocol  for  Integrations  with  pGTag  Vectors  using  CRISPR/Cas9    
  
Targeting  strategy  (Figure  1):    
  
A.   Selection  of  a  CRISPR/spCas9  target  site  downstream  of  the  first  AUG  in  the  gene  
of  interest  
B.   Synthesize  sgRNA  and  spCas9  mRNA  
C.   Injection  of  sgRNA  and  spCas9  mRNA  
D.   Testing  for  indel  production/mutagenesis    
E.   Design  short  homology  arms  
F.   One  Pot  Cloning  of  Homology  Arms  into  pGTag  Vectors  
G.   Injection  of  GeneWeld  reagents  (spCas9  mRNA,  Universal  sgRNA  (UgRNA),  
genomic  sgRNA  and  pGTag  homology  vector)  into  1-­cell  zebrafish  embryos  





Figure  1.  Targeting  integration  of  the  pGTag  vectors  into  the  5’  region  of  a  gene.    Upon  
CRISPR/Cas9  targeting  and  cutting  of  both  the  genome  (with  a  sgRNA)  and  plasmid  donor  (with  
UgRNA),  the  genomic  and  plasmid  DNA  likely  undergo  end  resection  mediated  by  the  MRN  
complex  and  ExoI,  resulting  in  annealing  of  complementary  homology  arms.  This  promotes  
precise  homology-­directed  integration  of  cargo  DNA  at  the  CRISPR/Cas9  double-­strand  break.  
  
A.   Selection  of  a  CRISPR/spCas9  target  site  downstream  of  the  first  AUG  in  the  gene  of  
interest  
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1.   To  select  a  CRISPR/Cas9  target  site  in  a  5’  exon,  find  and  download  the  targeted  gene’s  
genomic  and  coding  sequences.  
  
a.   At  <ensemble.org>  Search  for  the  gene  name  of  interest  for  the  species  of  interest  
and  open  the  Transcript  page.      
b.   In  the  left-­hand  side  bar  click  on  ”Exons”  to  find  the  first  coding  exon  and  initiation  
ATG.  If  there  are  alternative  transcripts  for  the    gene,  make  sure  there  are  not  
alternative  initiation  ATGs.  If  there  are  alternative  start  codons,  target  the  first  5’  exon  
that  is  conserved  in  all  transcripts  to  generate  a  strong  allele.    
c.   Download  the  transcript  and  5’  exon  to  be  targeted  as  separate  sequence  files.  
d.   Using    ApE:  <http://biologylabs.utah.edu/jorgensen/wayned/ape/>  annotate  the  
coding  sequence  with  the  exons.  
  
2.   Use  CRISPRScan  (http://www.crisprscan.org/)  (Moreno-­Mateos  et  al.,  2015)  to  
efficiently  identify  target  sites  and  generate  oligos  for  sgRNA  synthesis  for  the  target  
gene.  
  
a.   Select  the  “Predict  gRNAs”  on  the  lower  right-­hand  side  of  the  home  page  of  the  
CRISPRScan  website.  
b.   Paste  the  5’  exon  sequence  into  the  indicated  box.  If  the  exon  is  very  large,  start  with  
a  small  amount  of  sequence.  Ideally  exon  sequence  of  ~200  bp  near  the  desired  
target  site.  Do  not  design  CRISPRs  to  intron/exon  borders.  If  there  are  problems  with  
the  copy  and  pasting  of  exon  sequence,  first  paste  the  sequence  into  a  new  ape  file,  
save,  then  copy  and  paste  from  the  new  file.  
c.   Select  “Zebrafish  (Danio  rerio)”  as  the  species  
d.   Select  “Cas9  –  nGG”  as  the  enzyme.    
e.   Select  “In  vitro  T7  promoter”.  
f.   Click  on  “Get  sgRNAs.”  Examine  the  output.  The  generated  targets  are  ranked  by  
CRISPRScan  from  high  to  low.  Select  a  target  site  (the  20  bp  that  are  capitalized  in  
the  oligo  column)  from  those  given  by  CRISPRScan  using  the  following  criteria  (The  
best  gRNAs  will  have  all  of  these):  
  
i.   An  exact  match  to  the  genomic  locus.,  When  an  oligo  is  clicked  on  the  page  will  
display  additional  information  to  the  right.  In  the  section  called  “Site  Type”  any  
mismatches  in  the  oligo  are  displayed.  Exact  matches  including  5’GG-­  are  ideal  
for  in  vitro  transcription  and  100%  genomic  target  match.  
ii.   The  target  is  in  the  desired  location  of  the  gene.  
iii.   The  Target  is  on  the  reverse  (template)  strand.  Reverse  strand  guides  are  more  
favorable,  but  either  will  work  
iv.   A  high  CRISPRScan  score,  and  a  lower  CFD  score.  However,  lower  score  
sgRNA  targets  may  work  fine.    
  
g.   Annotate  the  selected  target  sequence  in  the  transcript  sequence  files.  
h.   For  sgRNA  synthesis  the  entire  oligo  sequence  from  CRISPRscan  containing  the  
selected  target  will  need  to  be  synthesized.  This  oligo  is  represented  as  “Oligo  A”  in  
Figure  2.  
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Figure  2.  Cloning-­free  gRNA  synthesis.  Oligo  A  is  composed  of  the  T7  promoter  at  the  5’  end,  
target  sequence  for  gRNA,  and  gRNA  overlap  sequence  for  gRNA  synthesis.  CRISPRScan  
provides  direct  output  for  Oligo  A.  The  strategy  for  gRNA  production  using  Oligo  A  is  based  on  
(Varshney  et  al.,  2015).  
  
3.   Alternative  to  CRISPRScan:  Designing  “CRISPR  Oligo  A”  from  a  genomic  target  
sequence.  Skip  this  section  if  Oligo  A  was  designed  with  CRISPRScan.    
  
If  the  target  sequence  was  identified  using  tools  other  than  CRISPRScan,  Oligo  A  can  be  
designed  manually.  (Note:  CRISPRScan  will  use  a  shorter  overlap  region  but  this  does  not  
affect  template  production).  Add  T7  and  Overlap  sequences  (see  Figure  2)  to  the  20  bp  of  






The  sequences  in  blue  (first  17  characters)  are  the  T7  promoter,  the  grey  GG  are  part  of  the  
T7  promoter  and  ideally  are  part  of  the  target  sequence  (see  below),  the  Ns  are  the  target  
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sequence,  and  the  sequence  in  green  (last  20  characters)  are  the  overlap  region  to  
synthesize  the  non-­variable  part  of  the  sgRNA.  The  T7  promoter  works  optimally  with  the  
two  grey  GGs,  however,  these  GGs  will  be  transcribed  by  T7  and  thus  become  a  part  of  the  
sgRNA.  Target  sequences  that  contain  the  GGs  may  work  better,  but  there  are  differing  
reports  in  the  literature  on  the  importance  of  this  (Moreno-­Mateos  et  al.,  2015).  If  possible,  
select  a  target  that  starts  with  GG.  Refer  to  Moreno-­Mateos  et  al.,  2015  for  other  gRNA  
architectures  with  variations  on  the  5’GG  motif.  
  
a.   If  the  target  sequence  did  not  have  two  Gs  at  the  beginning,  additional  G’s  will  need  
to  be  added  to  the  start  of  the  target  sequence  for  efficient  transcription  as  outlined  
below:  
  
*The  lower  case  ‘g’  is  an  extra  ‘G’  not  in  the  genomic  sequence;;  the  upper-­case  G  is  in  
the  genomic.  Lower  case  gs  will  not  base  pair  with  the  genomic  target.    
  
i.   without  GG:  ggN  NNN  NNN  NNN  NNN  NNN  NNN  N  (22  bp)  –  2  bases  are  
added,    
ii.   with  one  G:  gGN  NNN  NNN  NNN  NNN  NNN  NNN  (21  bp)  –  one  base  is  added,  
G  is  part  of  the  target  sequence.  
iii.   with  two  G:  GGN  NNN  NNN  NNN  NNN  NNN  NN  (20  bp)  –  no  bases  are  added,  
GG  is  part  of  the  target  sequence.  
Oligo  A  is  made  by  taking  this  target  sequence  with  5’GG  and  pasting  it  into  a  clean  file.  
  
b.   Copy  and  paste  the  T7  promoter  sequence  to  the  5’  end  of  the  target  sequence:    
TAATACGACTCACTATA  
c.   Copy  and  paste  the  Overlap  sequence  to  the  3’  end  of  the  target  sequence:  
GTTTTAGAGCTAGAAATAGC    
d.   Check  the  sequences  to  ensure  they  are  correct  and  that  the  PAM  is  NOT  present  in  
this  oligo.  
  
4.   Oligo  B  design  (Figure  2)  contains  the  conserved  guide  RNA  sequence:  All  Oligo  Bs  will  





5.   To  increase  yield  of  the  sgRNA  synthesis  the  primers  “T7  primer”                         
(5’-­TAATACGACTCACTATA-­3’)  and    “3’gRNA  primer”                            
(5’-­	  GATCCGCACCGACTCGGTG-­3’)  are  also  required.  
  
6.   For  checking  for  mutagenesis  at  the  target  site,  design  ~20  bp  DNA  primers  for  PCR  
amplification  to  amplify  at  least  130  bp  of  DNA  surrounding  the  target  site.  Mutagenesis  
is  estimated  through  comparison  of  PCR  products  from  injected  and  uninjected  embryos,  
by  visualizing  small  insertions  and/or  deletions  (Indels)  using  electrophoresis,  or  by  
sequencing.    
  
a.   Primer  3  is  used  for  primer  design:  
http://biotools.umassmed.edu/bioapps/primer3_www.cgi  
b.   Paste  DNA  sequence  surrounding  the  target  site  into  the  web  interface.  It  is  
recommended  to  use  160  –  300  bp  of  exon  sequence  centered  on  the  cut  site  for  
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primer  design.  Intron  sequence  can  be  used,  but  this  often  contains  polymorphisms  
that  can  lead  to  amplification  failure.    
  
c.   Locate  the  target  sequence,  including  the  PAM  sequence  (italicied  below),  and  
predict  the  cut  site  (3  bp  into  the  target  sequence  from  the  PAM  represented  here  by  
the  ‘x’).  Mark  the  targeted  exon  sequence  approximately  65-­150  bp  on  both  sides  of  
the  cut  site  by  putting  [square  brackets]  around  it.  Primer3  will  design  primers  outside  
this  sequence.  This  design  allows  the  primers  to  be  used  for  both  checking  of  








d.   Set  the  “Primer  Size”  variables  to  Min  =  130,  Opt  =  170,  and  Max  =  300.    Everything  
else  can  be  left  at  the  defaults.    
e.   Click  on  “Pick  Primers”  
f.   Select  primers  from  the  output.  Note  the  “product  size”  expected  and  the  “tm”  or  
melting  temperature  of  each  primer/pair.  Smaller  product  sizes  are  easier  to  visualize  
mutagenesis.  
  
B.   Synthesize  the  sgRNA  
  
General  guidelines  and  good  laboratory  practices  for  working  with  DNA  and  RNA.  DNA,  RNA  
and  the  enzymes  are  sensitive  to  contamination  from  dust  and  skin.  Following  these  guidelines  
will  prevent  the  degradation  of  the  DNA  and  RNA  you  are  trying  to  make:  
  
•   Be  clean.  Clean  the  workbench,  pipetmen,  racks,  and  centrifuges  with  RNase  Away  or  
something  equivalent.  
•   Wear  gloves  and  change  when  contaminated.  Contamination  will  occur  when  gloves  
contact  hair,  face,  skin,  or  the  floor.  
•   Keep  everything  on  ice  unless  the  protocol  indicates  otherwise.  
•   Centrifuge  components  to  the  bottom  of  the  tube  before  use,  after  mixing,  after  use,  and  
after  incubation  steps.    
•   Do  not  vortex  enzymes.  Gently  flick  the  tube  or  pipet  up  and  down  to  mix  samples.    
•   Avoid  touching  the  walls  of  the  tube  when  pipetting.  
•   Use  a  new  pipette  tip  for  each  new  dip.  
•   Dispense  solutions  from  a  pipet  to  the  bottom  of  the  tube,  or  into  the  liquid  at  the  bottom  
of  the  tube  when  setting  up  reactions.    
•   Only  remove  1.5  ml  centrifuge  tube  and  PCR  tubes  from  their  package  while  wearing  
gloves.  Reseal  the  tube  package  after  tubes  are  removed.  
  
Assembly  of  CRISPR  Oligos  A  +  B  into  a  Transcription  Template  
  
1.   For  synthesis  of  the  gRNA  from  Oligo  A  and  B,  make  a  100  μM  freezer  stock  and  1  μM  
working  stock  for  each  oligo.  All  oligos  are  described  in  Section  A  starting  on  page  7.  
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2.   Centrifuge  ordered  oligos  briefly  before  opening,  to  move  all  dried  DNA  flakes  to  the  
bottom  of  the  tube.  
  
3.   Add  a  volume  (x  μL)  of  RNase-­free  water  to  make  a  100  μM  stock.	  The  tubes  should  be  
labeled  with  the  gene  name  as  well  as  the  number  of  nmol  in  the  tube.  The  amount  of  
water  to  be  added  will  need  to  calculated  based  on  the  nanomoles  of  material  contained  
within.  
  
4.   Vortex  for  30  seconds.  
  
5.   Centrifuge  briefly.  
  
6.   Make  a  100-­fold  dilution  of  each  100  μM  stock  Oligo  A  and  B  in  separate  1.5  ml  tubes.    
a.   Label  one  1.5  mL  centrifuge  tube  per  Oligo  A  with  name  of  oligo,  date,  and  “1  μM”  to  
indicate  working  stocks.  
  
1  μL  of  100  μM  Oligo  A  stock  or  Oligo  B  
99  μL  of  RNF-­water  
100  μL  total  
  
b.   Vortex.  
c.   Briefly  centrifuge.    
d.   Store  all  stocks  in  freezer  at  -­20  oC  for  long-­term  storage.  
  
7.   Set  up  the  following  reaction  in  PCR  tubes.  The  next  two  steps  will  generate  a  short  
segment  of  DNA  (gDNA  or  guideDNA  Template)  which  will  be  used  as  a  template  for  
synthesis  of  RNA:  
  
12.5  μL  2X  KOD  Master  Mix  
1  μL  Oligo  A  (1  μM)    
1  μL  Oligo  B  (1  μM)  
1  uL  T7  primer    (10  μM)  
1  uL  gRNA  3’  primer  (10  μM)  
8.5  μL  RNF-­water    
25  μL  total  
  
8.   Run  PCR  under  the  following  conditions:  
  
Denature  at  98°C  for  2  minutes  
Denature  at  98  °C  for  30  sec.  
Anneal  at  50  °C  30  sec.  
Extend  at  70  °C  30  sec.  
Go  to  (step  2)  nine  times.  
Extend  at  70  °C  2  min  
Hold  4  oC  forever.  
  
9.   Run  1.2%  agarose  gel  in  1X  TAE  to  check  that  the  template  was  synthesized:  
  
a.   Remove  3  μL  of  the  reaction  and  place  in  a  1.5  ml  tube.    
b.   Mix  in  1  μL  of  6x  loading  buffer.    
c.   Load  all  4  μL  of  the  sample  on  the  gel.  Run  the  gel  at  125  V  for  30  minutes.  Be  sure  
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to  load  a  molecular  weight  marker.    
d.   Check  on  the  transilluminator  and  image  the  gel.  
e.   A  single  120  bp  band  should  be  detected  when  3  μL  is  loaded  on  gel.    
  
In  vitro  transcription  (IVT)  using  the  gRNA  template  
  
1.   Use  the  Ambion  T7  Megascript  Kit  for  transcription  reagents,  but  follow  the  instructions  
below.  
  
2.   Thaw  the  T7  10X  Reaction  Buffer  and  RNF-­water  at  room  temperature,  and  thaw  the  
ribonucleotides  solutions  on  ice.  
  
3.   Vortex  the  T7  10X  Reaction  Buffer  to  make  sure  all  DTT  is  solubilized.  No  white  flecks  
should  be  visible.  
  
4.   Microcentrifuge  all  reagents  briefly  before  opening  to  prevent  loss  of  reagents  and/or  
contamination  by  materials  that  may  be  present  around  the  rim  of  the  tube(s).    
  
5.   Keep  the  T7  Enzyme  Mix  on  ice  or  in  a  -­20  oC  block  during  assembly  of  the  reaction.    
  
6.   Make  a  master  mix  for  each  reaction.  Assemble  the  reaction  at  room  temperature  on  the  
bench.  Add  reagents  from  largest  to  smallest  volume,  adding  the  10X  Reaction  Buffer  
second  to  last  and  the  T7  Enzyme  Mix  last.    
 
Note: Components in the transcription buffer can lead to precipitation of the template DNA if the 
reaction is assembled on ice. If  the  reaction  precipitates,  the  synthesis  reaction  will  not  fully  
occur.  
  
7.   Reagent  list:  
  
10  μL  of  RNF-­water  
5  μL  of  gDNA  template  (100  to  500  ng  total)  
4  μL  of  NTP  (1  µl  of  each;;  A,  U,  C,  G)  
1  μL  of  10x  transcription  buffer  –  must  be  fully  resuspended  at  room  temp  
1  μL  of  T7  polymerase  enzyme  mix  
  
8.   Incubate  at  37  oC  for  4  to  16  hours.  Longer  incubations  result  in  considerably  better  
yields.  
  
9.   Add  1  μL  of  Turbo  DNAse  and  incubate  for  15  min  at  37  oC.  This  will  digest  the  template  
DNA  in  the  sample.  
  
10.  Optional  quality  control  step:  Run  2  μL  of  sample  on  a  1.2%  gel  in  1X  TAE.  
  
a.   Clean  the  gel  box,  comb  and  tray  with  RNase  Away,  rinse  with  DI  water.  
b.   Remove  2  µl  of  sample  into  a  clean  1.5  ml  (Keep  RNA  on  ice!)  
c.   Add 3 μL of RNF-water and 5 uL of Ambion RNA loading buffer with formamide.   
d.   Vortex  briefly.  
e.   Spin down samples briefly.   
f.   Run all of this mixture on a 1.2% agarose gel/1X TAE, at 100 V for 1 hour.  
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g.   Image  gel.  2  bands  should  be  visible  at  ~100  and  120  bp.  
 
Purification  of  guide  RNA  
  
1.   Use  the  miRNeasy  Qiagen  kit  for  purification  of  gRNAs  according  to  the  manufacturer’s  
instructions.    
2.   After  Purification  verify  presence  of  RNA  by  running  a  1.2%  gel  in  1X  TAE.  
3.   Clean  the  gel  box,  comb  and  tray  with  RNase  Away,  rinse  with  DI  water.  Run on a 1.5% 
agarose gel/1X TAE, at 100 V for 1 hour as above.   
4.   Image  gel.  2  bands  should  be  visible  at  ~100  and  120  bp.  
5.   Nanodrop  the  RNA  sample  to  determine  the  concentration.    
6.   Store  RNA  at  -­20  °C.  
  
  
Preparation  of  SpCas9  mRNA  
  
1.   Digest  ~5-­10  μg  pT3TS-­nCas9n  plasmid  with  Xba1  (plasmid  Addgene  #46757  (Jao  et  
al.,  2013)).  
  
2.   Purify  digested  DNA  with  Qiagen  PCR  cleanup  kit  or  Promega  PureYield  Plasmid  
Miniprep  System.  Elute  in  RNF-­water.  
  
3.   Run  100-­500  ng  on  1.2%  agarose  gel  in  1X  TAE  to  confirm  the  plasmid  is  linearized.  
  
4.   Use  100  ng  to  1  μg  DNA  as  template  for  in  vitro  transcription  reaction.  
  
5.   Use  mMESSAGE  mMACHINE  T3  kit  Life  Technologies  (AM1348)  and  follow  the  
instructions  in  the  manual.  
  
6.   Use  the  miRNeasy  Qiagen  kit  for  purification  of  nCas9n  mRNA  according  to  the  
manufacturer’s  instructions.    
  
7.   Verify  mRNA  integrity  by  mixing  1  uL  of  purified  Cas9,  4  μL  of  RNF  water,  5  μL  glyoxl  
dye  (Ambion).    
  
8.   Heat  mixture  at  50  oC  for  30  minutes,  then  place  on  ice.  
  
9.   Clean  the  gel  box,  comb  and  tray  with  RNase  Away,  rinse  with  DI  water.  
  
10.  Run  all  10  μL  of  RNA  mixture  on  1.2%  agarose  gel  in  1X  TAE at 100 V for 1 hour as 
above. One  band  should  be  visible  at  4.5  kb.  
  
11.  Nanodrop  the  RNA  sample  to  determine  the  concentration.  Concentrations  between  
0.45  and  1  μg/μL  are  expected.    
  
12.  Aliquot  and  store  RNA  at  -­80  °C.  
  
  
C.   Injection  of  sgRNA  and  spCas9  mRNA  
  
The  injections  here  are  designed  to  deliver  25  pg  of  gRNA  and  300  pg  of  Cas9  mRNA  in  2  nL  of  
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fluid  to  embryos  at  one-­cell  stage.    
  
Injection  trays  are  cast  with  1.2%  agarose  with  1X  embryo  media  (Zebrafish  Book;;  zfin.org)  
in  polystyrene  petri  dishes  (Fisher  No.  FB0875713).  Injection  trays  can  be  used  multiple  
times  and  stored  at  4*C  for  up  to  three  weeks  between  use.  
  
1.   Trays  are  pre-­warmed  to  28.5  oC    prior  to  injection  by  placing  them  in  the  28.5  oC  
incubator.    Try  to  mitigate  tray  cooling  while  not  in  use.      
  
2.   Glass  needles  are  pulled  from  Kwik-­Fil  borosilicate  glass  capillaries  (No.  1B100-­4)  on  a  
Flaming/Brown  Micropipette  puller  (Model  P-­97).  
  
Injection  samples  are  made  to  contain  the  following  diluted  in  RNF  water  or  injection  buffer  (final  
concentration:  12.5  mM  HEPES  pH  7.5,  25  mM  Potassium  Acetate,  37.5  mM  Potassium  
Chloride,  0.0125  %  glycerol,  0.025  mM  DTT  ph  7.5)  
  
a.   12.5  ng/μL  of  genomic  gRNA  
b.   150  ng/μL  of  mRNA  for  Cas9  
  
3.   Needles  are  loaded  with  1.5  to  2.5  μL  of  sample,  and  then  loaded  onto  a  micro-­
manipulator  attached  to  a  micro  injector  (Harvard  Apparatus  PLI  -­  90)  set  to  30-­40  PSI  
with  an  injection  time  of  200  msec.    
  
4.   Needles  are  calibrated  by  breaking  the  end  of  the  tip  off  with  sterile  tweezers,  ejecting  10  
times  to  produce  a  droplet  of  fluid,  collecting  the  droplet  into  a  1  μL  capillary  tube  
(Drummond  No.  1-­000-­0010),  and  measuring  the  distance  from  the  end  of  the  capillary  
to  the  meniscus  of  the  droplet.    This  distance  is  converted  to  volume  (where  1  mm  =  30  
nL)  and  adjusted  to  achieve  an  effective  injection  volume  of  2  nL.    Volumes  are  adjusted  
by  changing  the  injection  time.  There  is  a  linear  relationship  between  volume  and  time  at  
a  set  pressure.  Avoid  injection  times  less  than  100msec  and  over  400  msec.        
  
5.   One  cell  embryos  that  have  been  collected  from  mating  cages  are  pipetted  from  
collection  petri  dishes  to  the  wells  on  the  injection  tray.  
  
6.   Use  the  micro-­manipulator  and  microscope  to  pierce  the  one-­cell  of  embryos  on  the  
injection  tray  at  an  angle  of  30o  with  the  needle.  Inject  2  nL    of  sample  in  the  one-­cell  
near  the  center  of  the  cell-­yolk  boundary.  
  
7.   After  embryos  have  been  injected,  wash  them  from  the  injection  tray  into  a  clean  petri  
dish  with  embryo  media.  
  
8.   Keep  20  -­  40  embryos  separate  as  uninjected  controls.  Treat  and  score  the  control  
embryos  in  the  same  way  as  the  injected  embryos.      
  
9.   At  3  -­  5  hrs  post  injection  remove  any  unfertilized  or  dead  embryos  from  the  dishes.  This  
will  prevent  death  of  the  still  developing  embryos.  
  
D.   Testing  for  indel  production/mutagenesis    
  
Phenotypic  scoring  of  embryos  	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1.   The  gRNA  itself  may  be  toxic  to  the  developing  embryos.  Injection  toxicity  can  be  
estimated  by  the  number  dead  embryos  from  a  round  of  injection  compared  to  the  un-­
injected  control  dish.	  Count  and  remove  any  brown/dead  embryos  from  injected  and  un-­
injected  dishes.  If  there  are  significantly  more  dead  embryos  in  the  injected  dish  then  the  
guide  may  be  toxic,  impure,  or  very  effective  at  disrupting  a  required  gene.  Reducing  the  
amount  of  guide  or  Cas9  mRNA  injected  may  help  reduce  toxicity.  
  
2.   Score  and  document  embryonic  phenotypes	  on  days  1  -­  4  post  fertilization  (dpf).  Under  a  
dissection  microscope  examine  the  un-­injected  controls  and  injected  embryos,  and  sort  
the  embryos  into  categories.    
  
3.   Scoring  categories  
  
o   -­Severe-­  These  embryos  have  some  parts  that  look  like  a  control  embryos,  but  are  
missing  key  features.  Examples:  embryos  that  lack  their  head,  eyes,  or  tail,  or  
embryos  that  have  an  unnaturally  contorted  shape  or  are  asymmetric.  
  
o   -­Mild-­  These  embryos  appear  mostly  normal,  but  have  slight  defects  such  as  small  
eyes,  pericardial  edema,  shortened  trunk/tail,  or  curled/twisted  tails.      
  
o   -­Normal-­  appears  normal  and  similar  to  controls.  
  
Digestion  of  embryos  for  isolation  of  genomic  DNA  for  mutagenesis  analysis  
  
Genomic  DNA  (GDNA)  can  be  isolated  from  zebrafish  embryos  aged  between  1  and  5  dpf  using  
this  protocol.  Embryos  can  be  analyzed  as  individuals  or  as  pools  (maximum  5)  from  the  same  
injection.  
  
1.   Dechorionate  embryos,  if  they  have  not  emerged  from  the  chorion.  
  
2.   It  is  recommended  to  screen  a  minimum  of  3  embryos  from  each  scoring  category  for  
mutagenesis.  Place  each  embryo,  including  controls,  into  separate  PCR  tubes.  Remove  
as  much  of  the  fish  water  as  possible.  If  needed,  spin  briefly  and  remove  additional  
water.      
  
3.   Add  20  μL  of  50  mM  NaOH  per  embryo.      
  
4.   Heat  the  embryos  at  95oC  in  a  thermocycler  for  15  minutes.    
  
5.   Vortex  samples  for  10  seconds.  Be  sure  that  the  tubes  are  sealed  to  prevent  sample  
loss  while  vortexing.      
  
6.   Spin  samples  down  and  heat  for  an  additional  15  min  at  95  oC  in  a  thermocycler.      
  
7.  Vortex  samples  and  then  spin  the  tubes  down  again.  The  embryos  should  be  completely  
dissolved.      
  
7.   Neutralize  the  samples  by  adding  1  μL  of  1  M  Tris  pH  8.0  per  10  μL  NaOH.    Mix  by  vortexing  
then  spin  down.    
  
8.   Genomic  DNA  should  be  kept  at  4  oC  while  in  use  and  stored  at  -­20oC.  
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Analysis  of  CRISPR/Cas9  mutagenesis  efficiency  at  targeted  gene  locus.  
  
1.   Set  up  the  following  PCR  reactions  for  each  tube  of  digested  embryos  using  the  primers  
designed  at  the  end  of  section  A,  page  10.      
  
      12.5  μL  of  2x  GoTaq  Mastermix  
      1  μL  of  Forward  Primer  (10  uM)  
      1  μL  of  Reverse  Primer  (10  uM)  
      1  μL  of  gDNA  template  (digested  embryos)  
      9.5  μL  of  nuclease-­free  water  
      25  μL  total  
  
2.   Vortex  and  briefly  spin  down  the  PCR  reactions.  
  
3.   Run  the  following  PCR  program  to  amplify  the  targeted  locus.  
  
      95oC     2  minutes  
      95oC   30  seconds   ]  
      55oC*   30  seconds   ]  x  35  cycles  
      72oC   30  seconds   ]  
      72oC   5  minutes  
      4oC   hold  
   *if  the  primers  were  designed  with  higher  or  lower  tm’s  than  the  annealing  temperature  in  
line  three,  then  that  temperature  will  need  to  be  adjusted  to  2oC  below  the  designed  primer  tm.  
  
4.   Run  up  to  7  μL  of  PCR  product  on  a  3.0%  agarose  gel,  1X  TAE,  for  1  hr  at  80-­100V.      
  
5.   Analyze  the  gel  for  DNA  bands  that  appear  diffuse  or  different  in  size  from  the  control  
lane.  This  indicates  that  the  presence  of  indels  in  the  gene  of  interest  
  
6.   Alternatively  clone  and  sequence  PCR  products  or  sequence  them  directly  to  verify  the  
presence  of  indels.  
  
E.   Design  short  homology  arms  
  
Homology  directed  gene  targeting  allows  the  integration  of  exogenous  DNA  into  the  genome  
with  precision  to  the  base  pair  level.  However,  designing  and  cloning  individual  targeting  vectors  
and  homology  arms  for  each  gene  of  interest  can  be  time  consuming.  The  pGTag  vector  series  
provides  versatility  for  ease  of  generation  of  knockout  alleles  (Figure  3).  The  vectors  contain  
BfuAI  and  BspQI  type  II  restriction  enzymes  for  cloning  of  short  homology  arms  (24  or  48  bp)  
using  Golden  Gate  cloning.  The  pGTag  vectors  require  in-­frame  integration  for  proper  reporter  
gene  function.  The  reporter  gene  consists  of  several  parts.  First,  a  2A  peptide  sequence  causes  
translational  skipping,  allowing  the  following  protein  to  dissociate  from  the  locus  peptide.  
Second  and  third,  eGFP,  TagRFP,  or  Gal4VP16  coding  sequences  for  the  reporter  protein  have  
a  choice  of  sequence  for  localization  domains,  including  cytosolic  (no)  localization,  a  nuclear  
localization  signal  (NLS),  or  a  membrane  localization  CAAX  sequence.  Finally  translation  is  
terminated  by  one  of  two  different  polyadenylation  sequences  (pA);;  a  b-­actin  pA  from  zebrafish  
or  the  SV40pA.    
  
.CC-BY-NC 4.0 International licenseIt is made available under a 
was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint (which. http://dx.doi.org/10.1101/431627doi: bioRxiv preprint first posted online Oct. 3, 2018; 
	   12  
For  many  genes,  the  signal  from  integration  of  the  report  protein  is  too  weak  to  observe.  In  
these  cases  the  Gal4VP16  vector  allows  for  amplification  of  the  report  to  observable  expression  
levels  in  F0s  and  subsequent  generations.  A  14XUAS/RFP  Tol2  plasmid  is  provided  to  make  a  
transgenic  line  for  use  with  the  Gal4VP16  vector.    
  




Figure  3.  The  pGTag  vectors  allow  one  step  cloning  of  homology  arms.    
  
All  vectors  can  be  obtained  through  Addgene  (www.addgene.org).  Because  the  pGTag  
plasmids  contain  repeated  sequences,  they  may  be  subject  to  recombination  in  certain  strains  
of  bacteria.  It  is  strongly  recommended  that  they  are  propagated  at  30oC  to  reduce  the  
possibility  recombination.    
  
The  web  tool,  GTagHD  www.genesculpt.org/gtaghd/,  allows  for  quick  design  of  cloning  ready  
homology  arm  oligos  for  a  gene  of  interest.    
To  use  the  tool,  choose  the  "Submit  Single  Job"  tab.  Follow  the  instructions  in  the  tab.    
  
There  should  be  4  oligos  (two  pairs  that  will  be  annealed)  generated  that  should  be  ordered  for  
cloning.  If  there  are  any  problems  with  the  sequences  and  values  that  were  entered,  the  web  
page  will  display  the  errors  and  give  advice  on  how  to  fix  them.  
     
The  following  protocol  describes  how  to  design  homology  arm  oligos  manually:  
  
  *Note*  In  the  following  section  when  orientation  words  are  used,  they  are  used  in  the  context  of  
the  reading  frame  of  the  genetic  locus  of  interest.  Example:  A  5’  template  strand  CRISPR  
means  that  the  target  site  for  the  CRISPR  is  on  the  template  strand  at  the  locus  and  is  toward  
the  5’  end  of  the  gene.  Upstream  homology  domains  are  5’  of  the  CRISPR  cut  and  downstream  
homology  domains  are  3’  of  the  cut  with  respect  to  the  gene  being  targeted.  Also  note:  Upper  
case  and  lower  case  bases  are  not  specially  modified;;  they  are  typed  the  way  they  are  as  a  
visual  marker  of  the  different  parts  of  the  homology  arms.  
  
  
For  the  Upstream  Homology  Domain  
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1)    Open  the  sequence  file  for  the  gene  of  interest  and  identify  the  CRISPR  site.  (In  this  
example  it  is  a  Reverse  CRISPR  target  in  Yellow,  the  PAM  is  in  Orange,  coding  sequence  is  in  
purple)  
Copy  the  48  bp  5’  of  the  CRISPR  cut  (the  highlighted  section  below)  into  a  new  sequence  file;;  




2)    Observe  the  next  three  bases  immediately  upstream  of  the  48  bp  of  homology,  and  pick  a  
base  not  present  to  be  the  3  bp  spacer  between  the  homology  and  the  Universal  PAM  in  the  
vector.  (Here  the  three  bases  are  “GGA”  so  “ccc”  was  chosen  for  the  spacer)  
Add  the  spacer  to  the  new  file  5’  (in  front)  of  the  homology,  see  below.  The  spacer  acts  a  non-­
homologous  buffer  between  the  homology  and  the  eventual  6  bp  flap  from  the  universal  guide  
sequence  that  will  occur  when  the  cassette  is  liberated  and  may  improve  intended  integration  




3)    Determine  where  the  last  codon  is  in  the  homology.  Here  the  3’  G  in  the  homology  domain  is  
the  first  base  in  the  codon  cut  by  this  CRISPR  target.    Complete  the  codon  by  adding  the  
remaining  bases  (called  padding  on  GTagHD)  for  that  codon  from  your  sequence  to  ensure  your  




4)    Add  the  BfuAI  enzyme  overhang  sequences  for  cloning,  to  the  ends  of  the  homology  
domain.  5’-­GCGG  and  3’-­GGAT.  (Here  both  overhangs  are  added  to  prevent  errors  in  copying  
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5)    The  Upstream  Homology  Oligo  A  will  be  this  sequence  from  the  beginning  to  the  end  of  the  
last  codon  (see  highlighted  below).  Copy  and  paste  this  sequence  into  a  new  file  and  save  it.  In  





6)    The  Upstream  Homology  Oligo  B    will  be  the  reverse  compliment  of  this  sequence  from  
beginning  of  the  spacer  to  the  end  of  the  sequence  (see  highlighted  below).  Copy  the  reverse  





For  the  Downstream  Homology  Domain  
  
7)    Open  sequence  file  for  the  gene  of  interest  and  identify  the  CRISPR  site.  (Reverse  CRISPR  
target  in  Yellow,  PAM  in  Orange,  coding  sequence  is  in  purple)  





8)    Observe  the  next  three  bases  downstream  of  the  48  bp  of  homology,  and  pick  a  base  not  
present  to  be  the  3  bp  spacer  between  the  homology  and  the  Universal  PAM  in  the  vector.  
(Here  the  bases  are  “CTG”  so  “aaa”  was  chosen  for  the  spacer.)  




9)    Add  the  BspQI  enzyme  overhang  sequences  for  cloning,  to  the  ends  of  the  homology  
domain.  5’-­AAG  and  3’-­CCG.  (Here  both  overhangs  are  added  to  prevent  errors  in  copying  
sequence  for  the  oligos  in  the  next  two  steps.)  
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10)    The  Downstream  Homology  Oligo  A    will  be  this  sequence  from  the  beginning  of  the  





11)    The  Downstream  Homology  Oligo  B  (will  be  the  reverse  compliment  of  this  sequence  from  
the  beginning  of  the  homology  to  the  end  of  the  sequence  (see  highlighted  below).  In  this  






F.   One  Pot  Cloning  of  Homology  Arms  into  pGTag  Vectors  
  
**Note  if  the  homology  arm  oligos  contain  either  the  sequence  “5’-­ACCTGC-­3’”  or  “5’-­
GAAGAGC-­3’”  (or  their  compliments)  the  cloning  reaction  will  be  less  efficient.    
*Note  some  sequences  just  don’t  work  very  well.  Ligation  is  more  efficient  with  annealed  
homology  arms  and  the  purified  ~1.2  kb  and  ~2.4kb  fragments  from  vectors  that  have  
been  digested  with  BfuAI  and  BspQI.  If  problems  are  encountered,  one  homology  arm  
can  also  be  cloned  sequentially.    
  
1.   Homology  Arm  Annealing  
  
Anneal  upstream  and  downstream  homology  oligo  pairs  separately:  
  
   4.5  μL  oligo  A  at  10  uM  
   4.5  μL  oligo  B  at  10  uM  
   4  μL  10x  Buffer  3.1  from  NEB  
   27  μL  dH20  
   total  =  40  μL  
  
Incubate  at  98oC  for  4  min,  98oC  45  sec  x  90  steps  decrementing  temp  1oC/cycle,  
4oC  hold  
  
(Alternatively  heat  in  95-­98oC  water  for  5  minutes,  and  then  remove  the  boiling  beaker  from  
the  heat  source  and  allow  it  to  cool  to  room  temp  for  2  hours,  before  placing  samples  on  
ice.)  
  
2.   1-­Pot  Digest  
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Assemble  the  following:  
  
   4.0  μL  dH2O  
   2  μL  Plasmid  at  50  ng/uL  
   1  μL  10x  Buffer  3.1  from  NEB  
   1  μL  5'  annealed  homology  arm  
   1  μL  3'  annealed  homology  arm  
   0.5  μL  BfuAI  enzyme  from  NEB  
   0.5  μL  BspQI  enzyme  from  NEB  
   10  uL  total    
  
Incubate  at  50oC  for  1  hr,  place  on  ice.  
  
3.   Ligation  
  
   Add  the  following:  
  
   3  uL  5x  T4  quick  ligase  buffer  
   1.5  uL  dH2O  
   0.5  uL  T4  quick  ligase  
   15  uL  total  
  
Incubate  8-­10  min  at  room  temperature  (to  overnight).  Store  at  -­20  oC,  
  
4.   Transformation  
  
a.   On  ice,  thaw  1  (one)  vial  competent  cells  (50  μL)  for  every  2  ligation  reactions.  
(approx.  5  min).  It  is  recommended  to  use  NEB  Stable  Competant  E.  coli  (C3040H)  
cells  to  limit  recombination.    
b.   While  cells  are  thawing,  label  the  microcentrifuge  tubes  for  each  ligation  and  put  on  
ice.  
c.   Once  the  cells  are  thawed,  use  a  pipette  to  transfer  25  μL    of  the  competent  cells  into  
each  labeled  tube.      
d.   Add  1.5  μL  of  a  ligation  reaction  into  competent  cells  to  transform.    
a.   Amount  of  ligation  reaction  added  should  be  less  than  5%  of  volume  of  
competent  cells.  
e.   Mix  by  tapping  the  tube  several  times  or  gently  mixing  with  the  pipet  tip.  
a.   Do  NOT  mix  by  pipetting,  this  will  lyse  the  cells.  
f.   Incubate  on  ice  for  5  to  20  minutes.  
g.   Heat  shock  the  cells  by  submerging  the  portion  of  the  tube  containing  the  cells  in  a  
42oC  water  bath  for  40  -­  50  seconds.      
h.   Incubate  cells  on  ice  for  2  minutes.  
i.   Add  125  μL  of  room  temperature  LB  to  each  transformation.  
j.   Incubate  cells  at  30oC  for  1-­  1.5  hour(s)  in  a  shaking  incubator.  
k.   While  the  transformed  cells  are  recovering,  spread  40  μL  of  X-­Gal  solution,  and  40  
μL  IPTG  0.8  M  on  LB  Kanamycin  selection  plates.      
a.   X-­Gal  is  lethal  to  cells  while  wet,  it  is  recommended  to  first  label  the  plates  
and  then  place  them  in  a  30oC  incubator  to  dry.  
l.   After  recovery  and  the  X-­Gal  is  dry,  Plate  150  μL  of  each  transformation  on  the  
corresponding  correctly  labeled  plate.  
m.   Incubate  plates  overnight  at  30oC.  
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5.   Growing  colonies  
  
Pick  3  white  colonies  from  each  plate  and  grow  in  separate  glass  culture  tubes  with  3  mL  
LB/Kanamycin.  
  
   Or  to  pre-­screen  colonies  by  colony  PCR:  
a.   Pick  up  to  8  colonies  with  a  pipet  tip  and  resuspend  them  in  separate  aliquots  of  5  μL  
dH2O.  Place  the  tip  in  3  ml  of  LB/Kan,  label,  and  store  at  4oC.  
b.   Make  a  master  mix  for  your  PCR  reactions  containing  the  following  amounts  times  
the  number  of  colonies  you  picked.  
  
7.5  μL  2x  Gotaq  mastermix  
5.5  μL  dH2O  
0.5  μL  primer  at  10  uM  “F3'-­check”  5'-­  GGCGTTGTCTAGCAAGGAAG  -­3'  
0.5  μL  primer  at  10  uM  “3’_pgtag_seq”5'-­ATGGCTCATAACACCCCTTG-­3'  
14  μL  total  
  
c.   Aliquot  14  μL  of  mixed  master  mix  into  separate  labeled  PCR  tubes.  
d.   Add  1  μL  of  colony  to  each  reaction  as  template.  
e.   or  20  ng  purified  plasmid  as  control.  
f.   Cycle  in  a  thermocycler  
      95oC     2  minutes  
      95oC   30  seconds   ]  
      57oC   30  seconds   ]  x  35  cycles  
      72oC   30  seconds   ]  
      72oC   5  minutes  
      4oC   hold  
  
g.   Run  5  μL  of  PCR  product  on  a  1%  agarose  gel.  You  should  get  bands  that  are  a  
different  size  than  the  control.  
  
6.   Mini  Prep  Cultures  
  
   Follow  Qiagen  Protocol  
  
7.   Sequencing  of  Plasmids  
  
The  5’  homology  arm  can  be  sequenced  by  the  5'_pgtag_seq  primer:    
5'-­GCATGGATGTTTTCCCAGTC-­3’.  
The  3’  homology  arm  can  be  sequenced  with  the  “3’_pgtag_seq”primer:    
5'-­ATGGCTCATAACACCCCTTG-­3'.    
  
G.   Injection  of  GeneWeld  Reagents  (spCas9  mRNA,  Universal  sgRNA  (UgRNA),  genomic  
sgRNA  and  pGTag  homology  vector)  into  1-­cell  zebrafish  embryos  
  
Prepare  and  collect  the  following  reagents  for  injection  
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1.   Prepare  nCas9n  mRNA  from  pT3TS-­nCas9n  (Addgene  #46757  from  (Jao  et  al.,  2013))  
as  described  above  (page  14).  
  




   Corresponding  to  the  universal  target  sequence:  GGGAGGCGTTCGGGCCACAG  
  






3.   The  pGTag  homology  vectors  should  be  purified  a  second  time  prior  to  microinjection  
under  RNase  free  conditions  with  the  Promega  PureYield  Plasmid  Miniprep  System  
beginning  at  the  endotoxin  removal  wash  and  eluted  in  RNF  water.  
  
Embryo  Injections  for  Integration  of  pGTag  vectors  
  
Injections  are  performed  as  previously  described  in  2  nl  per  embryo  with  the  addition  of  the  
UgRNA  and  targeting  pGTag  DNA.    
  
Final  per  embryo:              Injection  mixture:  
  
150  pg  of  nCas9n  mRNA               75  pg/nl  of  nCas9n  mRNA  
    25  pg  of  genomic  gRNA           12.5  pg/nl  of  genomic  gRNA  
    25  pg  of  UgRNA              12.5  pg/nl  of  UgRNA    
    10  pg  of  pGTag  DNA                   5  pg/nl  of  pGTag  DNA    
  
H.   Examine  embryos  for  fluorescence  and  junction  fragments  
  
Embryos  are  examined  for  fluorescence  under  a  Zeiss  Discovery  dissecting  microscope  with  a  
1X  objective  at  70-­100X  magnification.  If  weak  signals  are  observed,  embryos  are  manually  
dechorionated,  and  viewed  on  glass  depression  well  slides.  If  no  or  weak  signals  were  
observed,  Gal4VP16  integrations  are  attempted  in  a  14XUAS-­RFP  background.  Embryos  
displaying  widespread  fluorescence  in  expression  domains  consistent  with  the  targeted  gene  
are  examined  for  junction  fragments  or  raised  to  adulthood  for  outcrossing.  
  
F0  Junction  fragment  analysis  between  the  genomic  locus  and  the  targeting  vector  is  carried  out  
by  isolating  DNA  from  embryos  followed  by  PCR.  The  following  primers  are  used  for  junction  
fragment  analysis  and  must  be  paired  with  gene  specific  primers  (5’  to  3’):  
  
5’  pGTag  junctions:  
  
R-­Gal4-­5'juncM     GCCTTGATTCCACTTCTGTCA       with  a  gene  specific  forward  primer  
R-­RFP-­5'junc      CCTTAATCAGTTCCTCGCCCTTAGA  
R-­eGFP-­5'-­junc     GCTGAACTTGTGGCCGTTTA  
  
3’  pGTag  junctions:    
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F-­Gal4-­3'juncM      GCAAACGGCCTTAACTTTCC      with  a  gene  specific  reverse  primer  
F-­Gal4-­3'juncJ      CTACGGCGCTCTGGATATGT  
F-­RFP-­3'junc      CGACCTCCCTAGCAAACTGGGG  
F-­eGFP-­3'junc      ACATGGTCCTGCTGGAGTTC  
  
PCR  amplification  of  junction  fragments  can  be  a  result  of  artifacts  (Won  and  Dawid,  2017),  so  it  
is  important  to  carryout  control  amplifications  with  injected  embryos  that  lack  the  genomic  
gRNA.  F0  analysis  by  PCR  of  junction  fragments  is  carried  out  to  examine  correct  targeting.  F-­
Gal4-­3'juncM  and  F-­Gal4-­3'juncJ  are  two  alternate  primers  for  amplification  of  junction  
fragments  from  the  Gal4  cassette  due  to  gene  specific  mis-­priming  depending  on  the  target  loci.  
  
7.5  μL  2x  Gotaq  mastermix  
5.5  μL  dH2O  
0.5  μL  primer  at  10  uM  genomic  primer  
0.5  μL  primer  at  10  uM  pGTag  primer  
14  μL  total  
  
1.   Aliquot  14  μL  of  mixed  master  mix  into  separate  labeled  PCR  tubes.  
2.   Add  1  μL  of  genomic  DNA  to  each  reaction  as  template.  
3.   Cycle  in  a  thermocycler  with  the  following  steps:  
   95oC     2  minutes  
   95oC   30  seconds   ]  
   55oC   30  seconds   ]  x  35  cycles  
   72oC   30  seconds   ]  
   72oC   5  minutes  
   4oC   hold  
  
4.   Run  5  μL  of  PCR  product  on  a  1.2  %  agarose  gel  in  1XTAE.  Putative  junction  fragments  
should  give  bands  that  are  of  predicted  size.  
F0  animals  that  are  positive  for  the  reporter  gene  are  raised  to  adults  then  outcrossed  and  
examined  for  fluorescence  as  above.  The  Gal4VP16  system  can  lead  to  silencing  resulting  in  
mosaic  patterns  in  F1  embryos.  F1  embryos  displaying  fluorescence  are  examined  for  junction  
fragments  as  above,  raised  to  outcross  to  make  F2  families  or  sacrificed  at  3  weeks  post  
fertilization  for  Southern-­Blot  analysis  of  integrations.  F0  and  F1  identified  fish  can  be  incrossed  
or  backcrossed  to  get  an  initial  impression  of  the  homozyogous  phenotypes.  It  is  recommended  
that  lines  are  continuously  outcrossed  once  established.  
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